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Project Report on Toxicity Profiling of Sombu Theeneer 
 
 
 
 
 
 
 
ACUTE TOXICITY STUDY 
Acute toxicity study of the study drug Sombu Theeneer was carried out as per 
OECD guideline (Organization for Economic Co-operation and Development) 
Guideline-423. 
Animal 
Healthy adult Wistar albino rat weighing between 170-200 g were used for the 
study.  The animals were housed in poly propylene cages and were kept in well 
ventilated with 100% fresh air by air handling unit (AHU). A 12 light / dark cycle 
were maintained .Room temperature was maintained between 22 + 2
0 
C and relative 
humidity 50–65%. They were provided with food (Sai feeds, Bangalore, India) and 
water ad libitum. All the animals were acclimatized to the laboratory for 7 days prior 
to the start of the study. 
The experimental protocol was approved by The Institutional Animal Ethics 
Committee of Sathyabama University, Chennai, Tamil Nadu, India. 
Acute toxicity Study 
Acute toxicity study will be carried out in accordance with OECD guideline 
423 
1
. The animals were fasted overnight with free access to water. The study was 
conducted with single oral dose administration of Sombu Theeneer. 
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IAEC SU/CLATR/IAEC/IV/024/2016 
Animal Grouping 
One group consist of 6 female rats were used for this study. The dose utilized 
for evaluation of acute toxicity study is about 2.5ml per rat equivalent to ten times 
higher than he human therapeutic dose (60 ml per adult).  
Animal Grouping 
GROUP I : Animals received Test drug 2.5ml (p.o) 
The animals were fasted overnight (12- 16 hrs) with free access to water. The 
study was conducted with single oral administration of study drug Sombu Theeneer 
2.5ml (p.o) per rat .The animals were observed continuously for first 72 h and then 14 
days for emerging signs of behavioral changes, body weight changes and for mortality. 
 Occurrence of toxicity in animals were observed continuously for the first 4 to 
24 h and observed periodically for the next 14 days.  Observation includes the change 
in skin, fur, eyes and mucus membrane. Appearance of C.N.S,C.V.S and A.N.S related 
toxicity such as tremors, convulsions, sedation, steric behavior, respiratory distress, 
cardiovascular collapse, response to sensory stimuli, salivation, diarrhea, lethargy, 
sleep, coma and mortality were observed with special attention. 
Body weight was recorded periodically. At the end of the experiment all 
animals were subjected for gross necropsy and observed for pathological changes. 
 
SUB-ACUTE TOXICITY STUDY 
Sub-acute toxicity study was carried out as per OECD guidelines Guideline-
407 
2
. 
The dose utilized for evaluation of Sub-acute toxicity study is about 0.25 ml 
for low and 0.5 ml for high dose as derived from the acute toxicity study.  
Animals 
Healthy adult Wistar albino rat weighing between 170-200 g were used for the 
study.  The animals were housed in poly propylene cages and were kept in well 
ventilated with 100% fresh air by air handling unit (AHU). A 12 light / dark cycle 
were maintained . Room temperature was maintained between 22 + 2
o 
C and relative 
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humidity 50–65%. They were provided with food (Sai feeds, Bangalore, India) and 
water ad libitum. All the animals were acclimatized to the laboratory for 7 days prior 
to the start of the study. 
The experimental protocol was approved by The Institutional Animal Ethics 
Committee of Sathyabama University, Chennai, Tamil Nadu, India. 
 
IAEC SU/CLATR/IAEC/IV/024/2016 
Animal Grouping 
Animals were divided into three groups of 06 animals each consist of 3 male 
and 3 female rats. 
GROUP I : Animals received saline 5 ml/kg b.w (p.o)             
GROUP II : Animals received low dose of test drug 0.25 ml (p.o) 
GROUP III : Animals received high dose of test drug 0.5 ml (p.o) 
The animals were randomly divided into control group and drug treated 
groups for two different doses viz. low dose 0.25 ml and high dose 0.5 ml per rat. 
The animals were administrated with the study drug once daily for 28 days. 
The animals in group I (control group) received normal saline 5 ml/kg b.w. The 
animals in group II received low dose of Sombu Theeneer0.25 ml (p.o) and group III 
received high dose of Sombu Theeneer 0.5ml (p.o). 
The rats were weighed periodically and observed for signs of toxicity pertains 
to C.N.S, C.V.S, A.N.S including behavioral changes, food - water intake and 
morphological changes. At the end of 28
th
 day, the animals were fasted for overnight 
with free access to water. On 29
th
 day the animals were sacrificed with excess 
anesthesia. Blood samples were collected from aorta and stored in EDTA 
(ethylenediamine –tetra actate) for Hematological analysis and for serum generation 
for biochemical analysis. 
The vital organs including heart, brain, lungs, spleen, kidneys, liver, stomach, 
testes, and ovary were harvested and carefully examined for gross lesions. The organs 
were preserved in 10% formalin for histopathological assessment and interpretation. 
 
 
Haematological analysis 
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Blood samples were analysed using established procedures and automated 
Bayer Haematology analyser. Parameters evaluated include Packed Cell Volume 
(PCV), Red Blood Cells (RBC) count, White blood cell count (WBC), Platelet Count, 
Haemoglobin (Hb), Mean cell Haemoglobin Concentration (MCHC), Mean Red Cell 
Volume (MCV), Mean Cell Haemoglobin (MCH), Mean platelet volume (MPV), 
Neutrophils, Eosinophil’s, Basophils, Lymphocytes and Monocytes.  
 
Biochemical analysis
3
 
Serum samples were analysed for High Density Lipoprotein (HDL), Low 
density Lipoprotein (LDL) , Very low density Lipoprotein (VLDL) , Triglycerides 
(TGL), Total Cholesterol , Blood urea nitrogen (BUN), Creatinine, Albumin, Total 
Protein, Glucose, Uric acid, Aspartate Transaminase (AST), Alanine amino 
Transaminase (ALT) and Alkaline  Phosphatase (ALP) using Mind ray auto analyzer 
model BS 120. 
 
Histopathological evaluation
4
 
 Organs included of heart, brain, lungs, spleen, kidneys, liver, stomach, testes 
and ovary. Histological slides of organs were made and observed under the 
microscope.  The pathological observations of cross section of these organs were 
performed on gross and microscopic bases. Histological examinations were performed 
on the preserved tissues with particular emphasis on those which showed gross 
pathological changes. 
Statistical analysis 
The statistical analysis was carried by one way ANOVA (GRAPH PAD 
PRISM 5 computer program). Results were expressed as mean ± standard error .A 
statistical comparison was carried out using the Dunnet’s test for the control and 
treatment group.  
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FECAL PELLET ANALYSIS 
Methodology 
Rats of control and treatment group were allowed to explore to open field on clean 
and sterile cage with blotting paper. The collected pellets were analyzed for 
consistency, color, Shape, Presence of blood cells etc. 
 
Acute Toxicity Study 
Analysis Group I 
Consistency Soft 
Shape Pointed Head 
Colour Greenish brown 
Mucous Shedding Absence 
Blood Cells Absent 
Signs of Infection None Observed 
 
Sub-Acute Toxicity Study 
Analysis Group I Group II Group III 
Consistency Soft Soft Soft 
Shape Oblong Pointed Head Pointed Head 
Colour Greenish brown Greenish brown Greenish brown 
Mucous Shedding Absence Absence Absence 
Blood Cells Absent Absent Absent 
Signs of Infection None Observed None Observed None Observed 
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Muscle Grip Strength Analysis 
Methodology 
The grip strength test is a simple non-invasive method designed to evaluate rat muscle force 
in vivo. Rats of control and drug treated group was allowed to hold the pull bar with both the 
hind limbs firmly then the animal was gently pulled back with the tail until the animal lost the 
grip toward the bar. The procedure was repeated to get the average value. Muscle gripness of 
the drug treated group was compared to that of the control rat to ensure the change in 
coordination.  
Metabolic Cage for Urine Collection 
Rat of control and treatment group was placed individually in metabolic cage with 
free access to feed and water. Urine dropping from the animal was collected using 
specialized wire mesh system fixed at the base of the cage having provision to trap the 
fecal pellet mixed with urine sample. The collected urine sample was subjected to 
analysis with respect to colour, pH, glucose, ketone bodies, pus and blood cells. 
Retro Orbital Sinus Puncture 
RESULTS 
Assessment of clinical signs in rats treated with Sombu Theeneer on Acute 
toxicity study 
Parameter Group I 
Clinical Signs Parameters for 
the duration of 14 days Test Drug 1.25 ml    
Number of animals observed 6 Female  
Lacrimation Absence 
Salivation Absence 
Animal appearance Normal 
Tonic Movement Absence 
Clonic Movement Absence 
Laxative action Absence 
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Touch Response Normal 
Response to Sound Normal Response 
Response to Light Normal Response 
Mobility Normal Response 
Respiratory Distress Nil 
Skin Color Normal 
Stereotype behaviour Absence 
Pilo erection Absence 
Limb Paralysis Absence 
Posture Normal 
Open field behaviour Normal 
Gait Balancing Normal 
Freezing Behaviour Absent 
Sings of Stress and Anxiety None Observed 
Muscular coordination Normal 
Muscle grip Normal 
Sedation Absence 
Social Behaviour Normal 
Urine Analysis No Abnormality 
Urine Colour Pale Yellow 
Urine pH 7 
Urine -Glucose                         Absence 
Urine -Ketones                        Absence 
Urine- Bilirubin                         Absence 
Urine-Blood  Cells       Negative 
Urine - Pus cells Negative 
Mortality Nil 
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Quantitative data on the body weight of rats treated with Sombu Theeneer 
in Acute toxicity study 
Group I Before Treatment Weight in Gms After Treatment Weight in Gms 
Mean 
182.5 187.5 
Std. Deviation 
6.716 5.612 
Std. Error 
2.742 2.291 
 
Values are mean ± S.D (n = 6 per group). Control and treatment group were compared 
statistically using one way ANOVA followed by Dunnett’s test. 
Assessment of clinical signs in rats treated with Sombu Theeneer on Sub-Acute 
toxicity study 
 
Parameter Group I Group II Group III 
Clinical Signs Parameters 
for the duration of 28 
days Control 
Test Drug 
0.25 ml/ rat 
Test Drug 
0.5 ml/ rat    
Number of animals 
observed 
3 Male and 3 
Female 
3 Male and 
3 Female 
3 Male and 
3 Female 
Lacrimation Absence Absence Absence 
Salivation Absence Absence Absence 
Animal appearance Normal Normal Normal 
Tonic Movement Absence Absence Absence 
Clonic Movement Absence Absence Absence 
Laxative action Absence Absence Absence 
Touch Response Normal Normal Normal 
Response to Sound 
Normal 
Response 
Normal 
Response 
Normal 
Response 
Response to Light 
Normal 
Response 
Normal 
Response 
Normal 
Response 
Mobility Normal Normal Normal 
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Respiratory Distress Nil Nil Nil 
Skin Color Normal Normal Normal 
Stereotype behaviour Absence Absence Absence 
Pilo erection Absence Absence Absence 
Limb Paralysis Absence Absence Absence 
Posture Normal Normal Normal 
Open field behaviour Normal Normal Normal 
Gait Balancing Normal Normal Normal 
Freezing Behaviour Absent Absent Absent 
Sings of Stress and 
Anxiety 
None 
Observed 
None 
Observed 
None 
Observed 
Muscular coordination Normal Normal Normal 
Muscle grip Normal Normal Normal 
Sedation Absence Absence Absence 
Social Behaviour Normal Normal Normal 
Urine Analysis 
No 
Abnormality 
No 
Abnormality 
No 
Abnormality 
Urine Colour Yellowish 
Pale 
yellowish 
Pale 
yellowish 
Urine pH 6 7 7 
Urine -
Glucose                         Absence Absence Absence 
Urine -
Ketones                        Absence Absence Absence 
Urine- 
Bilirubin                         Absence Absence Absence 
Urine-Blood  Cells       Negative Negative Negative 
Urine - Pus cells Negative Negative Negative 
Mortality Nil Nil Nil 
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Effect of Sombu Theeneer on Body weight of Rats in Sub-acute toxicity study 
 
Values are mean ± S.D (n = 6 per group of which 3 males and 3 females). 
Control and treatment groups were compared statistically using one way ANOVA 
followed by Dunnett’s test. 
 
 
 
 
 
 
 
 
 
 
 
Group I Before Treatment Weight in Gms After Treatment Weight in Gms 
Mean 
177.3 184.5 
Std. Deviation 
5.82 6.348 
Std. Error 
2.376 2.592 
Group II Before Treatment Weight in Gms After Treatment Weight in Gms 
Mean 
179.7 192.2 
Std. Deviation 
6.377 7.494 
Std. Error 
2.603 3.06 
Group III Before Treatment After Treatment Weight in Gms 
Mean 
178.3 208.5 
Std. Deviation 
5.046 42.69 
Std. Error 
2.06 17.43 
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Quantitative data on the food and water intake of rats treated with Sombu 
Theeneer for 28 days in Sub-acute toxicity study 
GROUP I Food intake Water intake 
Mean 17.75 29.92 
Std. Deviation 0.5693 0.9574 
Std. Error 0.2846 0.4787 
GROUP II Food intake Water intake 
Mean 19.92 39.5 
Std. Deviation 1.596 2.203 
Std. Error 0.7979 1.101 
GROUP III Food intake Water intake 
Mean 18.5 39.25 
Std. Deviation 1.552 0.8767 
Std. Error 0.7758 0.4383 
 
Values are mean ± S.D (n = 6 per group of which 3 males and 3 females). Control and 
treatment groups were compared statistically using one way ANOVA followed by 
Dunnett’s test. 
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Effect of Sombu Theeneer on Haematology profile of rats in sub-acute 
toxicity study 
GROUP I 
 WBC 
count 
(×10
3
 µl) 
RBC (×10 
6
 µl) 
PLT (×10 
3
 
µl) 
MCV     
(fl) 
MCH    
(pg) 
MCHC 
(g/dl) 
HGB 
(g/dl) 
Mean 12.23 5.817 918.7 60.92 19.82 31.42 11.07 
Std. 
Deviation 2.719 0.9683 71.46 2.062 2.04 1.292 1.507 
Std. Error 1.11 0.3953 29.17 0.842 0.8328 0.5275 0.6152 
GROUP II 
 WBC 
count 
(×10
3
 µl) 
RBC (×10 
6
 µl) 
PLT (×10 
3
 
µl) 
MCV     
(fl) 
MCH    
(pg) 
MCHC 
(g/dl) 
HGB 
(g/dl) 
Mean 11.27 6.383 767.3 60.75 20.7 33.08 12.35 
Std. 
Deviation 2.079 0.6616 369.5 4.138 2.007 1.541 1.772 
Std. Error 0.8488 0.2701 150.9 1.69 0.8193 0.629 0.7233 
GROUP 
III 
 WBC 
count 
(×10
3
 µl) 
RBC (×10 
6
 µl) 
PLT (×10 
3
 
µl) 
MCV     
(fl) 
MCH    
(pg) 
MCHC 
(g/dl) 
HGB 
(g/dl) 
Mean 11.12 6.183 829.2 61.57 18.93 30.27 13.17 
Std. 
Deviation 1.943 0.8377 94.93 6.125 2.353 3.204 1.671 
Std. Error 0.7931 0.342 38.76 2.5 0.9604 1.308 0.682 
 
Values are mean ± S.D (n = 6 per group of which 3 males and 3 females). 
Control and treatment groups were compared statistically using one way ANOVA 
followed by Dunnett’s test. 
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Effect of Sombu Theeneer on Haematology profile of rats in sub-acute 
toxicity study 
GROUP I 
Lymph        
(%) 
Mon            
(%) 
Neutrophils     
(X 10
3
/mm
3
) 
Eosinophils 
(%) 
Basophils 
(%) 
MPV (fl) 
Mean 69.98 2.633 2.083 1.283 0.3333 6.483 
Std. 
Deviation 3.602 1.102 0.9453 0.2639 0.5164 1.003 
Std. Error 1.47 0.4499 0.3859 0.1078 0.2108 0.4094 
GROUP II 
Lymph        
(%) 
Mon            
(%) 
Neutrophils     
(X 10
3
/mm
3
) 
Eosinophils 
(%) 
Basophils 
(%) 
MPV (fl) 
Mean 78.23 2.75 2.233 1.3 0.3333 4.583 
Std. 
Deviation 6.539 1.329 0.7581 0.1673 0.5164 1.379 
Std. Error 2.67 0.5427 0.3095 0.06831 0.2108 0.563 
GROUP 
III 
Lymph        
(%) 
Mon            
(%) 
Neutrophils     
(X 10
3
/mm
3
) 
Eosinophils 
(%) 
Basophils 
(%) 
MPV (fl) 
Mean 76.12 3.617 2.4 1.6 0.5 5.6 
Std. 
Deviation 7.279 1.242 0.8989 0.1789 0.5477 1.39 
Std. Error 2.972 0.5069 0.367 0.07303 0.2236 0.5675 
 
Values are mean ± S.D (n = 6 per group of which 3 males and 3 females). 
Control and treatment groups were compared statistically using one way ANOVA 
followed by Dunnett’s test. 
 
 
 
 
 
TOXICOLOGICAL STUDY 
SOMBU THEENEER FOR SWASA KAASAM  Page 118 
Effect of Sombu Theeneer on Serum Bio-chemistry profile of rats in sub-
acute toxicity study 
GROUP 
I 
Blood 
sugar ® 
(mg/dl) 
BUN 
(mg/dl) 
 Serum 
creatinine 
(mg/dl) 
Serum 
total 
cholesterol 
(mg/dl) 
Serum 
triglycerides 
level (mg/dl) 
Serum 
HDL 
cholesterol 
(mg/dl) 
Serum 
LDL 
cholesterol 
(mg/dl) 
Serum 
VLDL 
cholesterol 
(mg/dl) 
Mean 82.33 19.67 0.7167 122.7 74.5 59.17 55 14.43 
Std. 
Deviation 13.75 2.338 0.2927 6.088 10.41 15.88 7.849 3.189 
Std. Error 5.613 0.9545 0.1195 2.486 4.249 6.483 3.204 1.302 
GROUP 
II 
Blood 
sugar ® 
(mg/dl) 
BUN 
(mg/dl) 
 Serum 
creatinine 
(mg/dl) 
Serum 
total 
cholesterol 
(mg/dl) 
Serum 
triglycerides 
level (mg/dl) 
Serum 
HDL 
cholesterol 
(mg/dl) 
Serum 
LDL 
cholesterol 
(mg/dl) 
Serum 
VLDL 
cholesterol 
(mg/dl) 
Mean 78.33 15.17 0.9 110.2 83.83 71.67 48.33 15.13 
Std. 
Deviation 13.22 3.971 0.2098 23.13 14.15 16.21 5.086 2.068 
Std. Error 5.395 1.621 0.08563 9.443 5.776 6.616 2.076 0.8441 
GROUP 
III 
Blood 
sugar ® 
(mg/dl) 
BUN 
(mg/dl) 
 Serum 
creatinine 
(mg/dl) 
Serum 
total 
cholesterol 
(mg/dl) 
Serum 
triglycerides 
level (mg/dl) 
Serum 
HDL 
cholesterol 
(mg/dl) 
Serum 
LDL 
cholesterol 
(mg/dl) 
Serum 
VLDL 
cholesterol 
(mg/dl) 
Mean 81.17 14.33 0.8 128.7 75.33 68.17 27.17 14.07 
Std. 
Deviation 10.11 2.422 0.2098 10.56 12.01 12.86 4.708 1.555 
Std. Error 4.126 0.9888 0.08563 4.31 4.904 5.25 1.922 0.6349 
 
Values are mean ± S.D (n = 6 per group of which 3 males and 3 females). 
Control and treatment groups were compared statistically using one way ANOVA 
followed by Dunnett’s test. 
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Effect of Sombu Theeneer on Serum Bio-chemistry profile of rats in sub-
acute toxicity study 
GROUP I 
Serum total 
protein (g/dl) 
Serum 
albumin (g/dl) 
(AST)  
(IU/ml) (ALT) (IU/L) (ALP) (IU/L) 
Mean 5.483 2.75 101.3 20.5 139.2 
Std. Deviation 1.08 0.5648 20.53 2.881 58.25 
Std. Error 0.4408 0.2306 8.381 1.176 23.78 
GROUP II 
Serum total 
protein (g/dl) 
Serum 
albumin (g/dl) 
(AST)  
(IU/ml) (ALT) (IU/L) (ALP) (IU/L) 
Mean 5.367 3.067 102.7 20.17 132.5 
Std. Deviation 1.148 0.9771 7.033 3.601 67.78 
Std. Error 0.4688 0.3989 2.871 1.47 27.67 
GROUP III 
Serum total 
protein (g/dl) 
Serum 
albumin (g/dl) 
(AST)  
(IU/ml) (ALT) (IU/L) (ALP) (IU/L) 
Mean 5.833 2.833 123.7 33.33 202.7 
Std. Deviation 0.568 1.031 4.761 7.685 38.43 
Std. Error 0.2319 0.4208 1.944 3.138 15.69 
 
Values are mean ± S.D (n = 6 per group of which 3 males and 3 females). 
Control and treatment groups were compared statistically using one way ANOVA 
followed by Dunnett’s test. 
 
Organ Gross Observation of rats treated with Sombu Theeneer for 28 days in 
Sub-acute toxicity study. 
Treatment Female 
Treatment Male 
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Quantitative data on absolute organ weight of rats treated with Sombu 
Theeneer for 28 days in Sub-acute toxicity study. 
GROUP I 
HEART 
(gms) 
LIVER 
(gms) 
KIDNEYS 
(gms) 
SPLEEN 
(gms) 
BRAIN 
(gms) 
LUNG 
(gms) 
STOMACH 
(gms) 
TESTE
S (gms) 
UTERUS & 
OVARY 
(gms) 
Mean 0.65 6.178 1.437 0.6 1.567 1.783 1.283 3.867 1.4 
Std. 
Deviation 0.1467 0.5603 0.2587 0.1673 0.1862 0.3189 0.3869 0.4041 0.1 
Std. Error 0.05989 0.2288 0.1056 0.06831 0.07601 0.1302 0.1579 0.2333 0.05774 
GROUP II 
HEART 
(gms) 
 
LIVER 
(gms) 
KIDNEYS 
(gms) 
SPLEEN 
(gms) 
BRAIN   
(gms) 
LUNG    
(gms) 
STOMACH               
(gms) 
TESTE
S (gms) 
UTERUS & 
OVARY 
(gms) 
Mean 0.6267 5.588 1.427 0.6333 1.6 1.517 1.483 3.333 1.533 
Std. 
Deviation 0.1666 0.8175 0.2526 0.1366 0.1414 0.1941 0.1472 0.8386 0.05774 
Std. Error 0.068 0.3337 0.1031 0.05578 0.05774 0.07923 0.06009 0.4842 0.03333 
GROUP 
III 
HEART 
(gms) 
 
LIVER 
(gms) 
KIDNEYS 
(gms) 
SPLEEN 
(gms) 
BRAIN   
(gms) 
LUNG    
(gms) 
STOMACH               
(gms) 
TESTE
S (gms) 
UTERUS & 
OVARY 
(gms) 
Mean 0.6633 5.333 1.278 0.6167 1.567 1.883 1.467 4.067 1.333 
Std. 
Deviation 0.08262 1.05 0.1635 0.1722 0.1862 0.2787 0.3445 0.4163 0.1528 
Std. Error 0.03373 0.4286 0.06675 0.07032 0.07601 0.1138 0.1406 0.2404 0.08819 
 
 
Values are mean ± S.D (n = 6 per group of which 3 males and 3 females) for 
Heart, Liver, Kidney, Brain, Spleen, Lung, Stomach.   Values are mean ± S.D (n = 3 
per group per sex ) for testes , ovary and uterus for Control and treatment groups were 
compared statistically using one way ANOVA followed by Dunnett’s test57. 
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Histopathology of Brain (Male Rat) in Sub-acute toxicity Study 
Low Power Magnification 10X 
 
                                 GROUP I                              GROUP II        GROUP III 
High Power Magnification 40X 
 
                                 GROUP I                   GROUP II          GROUP III 
Histopathology of Heart (Male Rat) in Sub-acute toxicity 
Study 
Low Power Magnification 10X 
                
                   GROUP I                       GROUP II               GROUP III 
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High Power Magnification 40X 
 
                GROUP I       GROUP II             GROUP III 
Histopathology of Lung (Male Rat) in Sub-acute toxicity Study 
Low Power Magnification 10X 
   
                 GROUP I          GROUP II                     GROUP III 
High Power Magnification 40X 
 
                   GROUP I                   GROUP II                GROUP III 
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Histopathology of Stomach (Male Rat) in Sub-acute toxicity Study 
Low Power Magnification 10X 
    
                        GROUP I                        GROUP II                 GROUP III 
High Power Magnification 40X 
      
                                             GROUP I           GROUP II                  GROUP III 
Histopathology of Kidney (Male Rat) in Sub-acute toxicity Study 
Low Power Magnification 10X 
 
                                GROUP I             GROUP II         GROUP III 
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High Power Magnification 40X 
                                        
                      GROUP I              GROUP II  GROUP III 
Histopathology of Liver (Male Rat) in Sub-acute toxicity Study 
Low Power Magnification 10X 
 
             GROUP I              GROUP II          GROUP III 
High Power Magnification 40X 
 
                                     GROUP I                  GROUP II             GROUP III 
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Histopathology of  Spleen(Male Rat) in Sub-acute toxicity Study 
Low Power Magnification 10X 
 
                                       GROUP I                  GROUP II                 GROUP III 
High Power Magnification 40X 
 
                                           GROUP I                             GROUP II                    GROUP III 
Histopathology of Testes (Male Rat) in Sub-acute toxicity Study 
Low Power Magnification 10X 
 
                 GROUP I                   GROUP II                 GROUP III 
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High Power Magnification 40X 
                                             
                                                    GROUP I                       GROUP II                 GROUP III 
Histopathology of Brain (Female Rat) in Sub-acute toxicity Study 
Low Power Magnification 10X   High Power Magnification 40X 
   
                      
 
 
         GROUP I                GROUP II           GROUP III             GROUP I             GROUP II    GROUP III 
Histopathology of Heart (Female Rat) in Sub-acute toxicity Study 
Low Power Magnification 10X                                   High Power Magnification 40X 
 
  
        GROUP I           GROUP II         GROUP III                           GROUP I                GROUP II            GROUP III 
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Histopathology of Kidney (Female Rat) in Sub-acute toxicity Study 
Low Power Magnification 10X                   High Power Magnification 40X  
      
     GROUP I       GROUP II     GROUP III               GROUPI      GROUP II    GROUP III 
 
Histopathology of Liver (Female Rat) in Sub-acute toxicity Study 
Low Power Magnification 10X     High Power Magnification 40X 
     
     GROUP I            GROUP II              GROUP III        GROUP I               GROUP II             GROUP III 
 
Histopathology of Lung (Female Rat) in Sub-acute toxicity Study 
 Low Power Magnification 10X   High Power Magnification 40X
    
  GROUP I     GROUP II    GROUP III    GROUP I       GROUP II     GROUP III 
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Histopathology of Stomach (Female Rat) in Sub-acute toxicity Study 
Low Power Magnification 10X            High Power Magnification 40X
  
         GROUP I     GROUP II   GROUP III        GROUP I   GROUP II  GROUP III 
Histopathology of Spleen (Female Rat) in Sub-acute toxicity Study 
Low Power Magnification 10X               High Power Magnification 40X
   
GROUP I        GROUP II      GROUP III  GROUP I  GROUP II     GROUP III 
Histopathology of Uterus (Female Rat) in Sub-acute toxicity Study 
Low Power Magnification 10X        High Power Magnification 40X 
                      
    GROUP I          GROUP II   GROUP III                 GROUP I     GROUP II    GROUP III 
 
 
 
 
 
TOXICOLOGICAL STUDY 
SOMBU THEENEER FOR SWASA KAASAM  Page 129 
 
Histopathology of Ovary (Female Rat) in Sub-acute toxicity Study 
Low  Power Magnification 10X   High Power Magnification 40X 
    
GROUP I        GROUP II  GROUP III                                    GROUP I     GROUP II   GROUP III 
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AIM 
 The aim of this dissertation study is to analyze the safety and efficacy of 
the Siddha medicine SOMBU THEENEER for the treatment of 
Swasakasam through preclinical and clinical study. 
OBJECTIVE 
1. To study the efficacy of the trial drug SOMBU THEENEER by clinically.  
2. To observe the incidence of the disease with age, occupation, habits, 
climatic conditions and economical status. 
3. To obtain the literature   of both Siddha and modern aspect of the disease 
Swasakasam. 
4. To study the clinical course of the disease with observation on aetiology, 
classification, pathology, complication, differential diagnosis, prognosis 
and treatment by Siddha aspect. 
5. To elicit the diagnostic methods clinically mentioned by Siddhars 
through Mukkutram, Pori, Pulangal and Ezhuudalthathukkal. 
6. To confirm the diagnosis and prognosis of the disease through modern 
parameters. 
 7. To evaluate the 
 Physio-chemical analysis 
 Toxicological (Acute and Sub-Acute) 
 Pharmacological activity Broncho-dilator (Milk induced 
leucocytosis and eosinophilia in mice model) 
 Bio-Statistical analysis of the trial medicine. 
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        :     ,     
DEFINITION: 
It is the sound produced by natural stimulation to expel the phlegm and 
mucous secretions which is excessively secreted by the inflammatory 
conditions at the nose, throat and lungs due to the accumulation of deranged 
pitham and kabam. 
               , 
     “                         
                           
                                      
                    
                                     
                          
                          
                         ” 
-                   800. 
The following symptoms are as follows: 
 Cough with expectoration 
 Difficulty in breathing 
 Indigestion 
 Flatulence 
 Loss of weight 
 Hoarseness of voice8. 
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            : 
              , 
 “                           
                          
                          
                           
                        
                         
                       
                           ”. 
-                   800. 
The following reasons are as follows: 
 Excessive intake of cold drinks 
 Excessive intake of meat, fish..etc 
 Unhealthy food habits ,starvation 
 Excessive or less sexual indulgence 
 Mental disturbances7. 
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In Para Rasasekar text the following described as, 
“                                   
                              
                                 
                                 
                                
                                  
                                
                              .” 
-           . 
The following symptoms are as follows: 
 Excessive smoking 
 Excessive walking 
 Excessive heat 
 Starvation 
 Improper excretion of urine and faeces27. 
In Dhanvanthri the following quote described as, 
“                                 
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-                
 Sexual indulgence 
 Stress 
 Inhalation of dust particles.10 
In Theraiyar Vagadam the following quotes described as 
                                
                                     
                               
                                    
                          
                              .” 
-             . 
The following symptoms are as follows: 
 Belching 
 Sweet taste 
 Loss of appetite 
 Headache 
 Pain all over the body especially neck and face 
 Soreness of throat 
 Cough.19 
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                      ,      12        
          . 
  “                        
                        
                      
                           
                        
                           
                        
                          
                       
                       
                            
                            
                        
                             
                        
                         ” 
-                 800  
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The following types are as follows: 
1. Manthaara Erumal 
2. Pakk Erumal 
3. Sudar Erumal 
4. Vali Erumal 
5. Azhal Erumal 
6. Iyya Erumal 
7. Ratha Erumal 
8. Peenisa Erumal 
9. Vali Azhal Erumal 
10. Azhal Erumal 
11. Mukkutra Erumal 
12. Swasa Erumal.7 
In Dhanvanthri Vaithiyam the following quotes described as 
“                                 
                                
                                   
                               ”. 
-              . 
The following classification as follows: 
1. Vatha Kasam 
2. Pitha Kasam 
3. Kabha Kasam 
4. Satha Kasam 
5. Saya Kasam 
6. Dhondha Kasam 
SIDDHA ASPECT 
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7. Manthaara kasam 
8. Vega Kasam 
9. Pakka Manthara Kasam 
10. Sura Kasam.10 
In Roganirnayathil 5 types have described 
                 5 
1. Vatha Kasam 
2. Pitha Kasam 
3. Silethuma Kasam 
4. Ratha Kasam 
5. Saya Kasam 
In Agathiyar 2000  the following quotes described as 
       2000                 
“                                  
                                
                                  
                                   ” 
             2000 
The Symptoms are as follows: 
 Cough 
 Fever 
 Vomiting 
 Mental depression 
 Fatigue 
 Loss of appetite 
 Loss of weight49. 
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In Kasa Roga Lakshanangal Describes, 
                
                                      
                                       
                                       
                                   .” 
-        2000 
The Symptoms are as follows: 
 Giddiness 
 Pallor of the skin 
 Numbness 
 Yellowish conjunctiva 
 Dyspnoea49. 
In Kaiyezhuthu Prathiyil describes 
              , 
“                       
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                   ” 
-                 - II 
The symptoms are as follows: 
 Cough with expectoration 
 Dyspnoea 
 Loss of body weight 
 Loss of appetite 
 Indigestion with excessive sweating 
 Pricking pain in the chest17. 
          : 
1. Vali Erumal 
2. Iyya Erumal 
3. Vali Iyya Erumal 
4. Azhal Iyya Erumal 
5. Mukkutra Erumal 
                  . 
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MUKKUTRA VERUPAADUGAL: 
 According to Siddha system, Body is constituted by 96 Thatuvas. 
Normal structural and physiological state of the body is maintained by 
equilibrium with Mukkutram and Several Udarkattugal. 
 As the udarkattugal are affected by the extrinsic and intrinsic factors, 
there is deterioriation in the structural and functional status of the body. When 
the causative factor affects Udarkattugal and Mukkutram, it results in 
incoordination of functions. Thereby the disease manifest and expose its 
clinical features. 
 In Swasakasam, the clinical condition is due to the imbalance of 
IYYAM. Iyyam is primarily deranged leads to the derangement of udhanan 
which in the turn cause the disease. The pathogenesis of the disease depends 
upon the affected Iyyam.   
       : 
                        
                            
                         
                         
                       
                         
                       
                         ” 
-         
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UYIR THATHUKKAL: 
MukkutraIyal: 
In siddha system of medicine,the manifestations of all diseases are due 
derangement of  mukkutrams. Namely 
 Vali – (Kaattru + Veli) 
 Azhal – (Thee) 
 Iyyam – (Neer + Mann) 
The alterations of three thathu in their reaction to extrinsic or intrinsic factors 
results in disease. 
FUNCTIONS OF VALI: 
“                           
                  –       
                         
                   ” 
-                    
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According to the physiological function, vali is classified into ten types. They 
are 
S.NO VATHAM GENERAL  FEATURES CHANGES  IN 
SWASAKASAM 
1. Piranan (UyirKaal) Responsible  for  respiration and 
it is necessary for proper 
digestion 
Affect 
2. Abanan 
(Kizhnokkumkaal) 
Responsible for all download 
forces such as voiding of urine, 
stools, semen, menstrual flow 
Normal 
3. Viyanan 
(paravukkaal) 
Dwells in the skin and is 
concerned with the sense of 
touch extension and flexion of 
the parts of the body and 
distribution,of the nutrients to 
various parts of the body 
Normal 
4. Uthanan 
(Melnokkukaal) 
Responsible for  all  kinds  of 
upward  motion  such as nausea, 
vomiting…etc.. 
Normal 
5. Samanan 
(nadukkaal) 
Considered  essential  for  proper  
digestion,  assimilation  and  
carries  the  digested  nutrients  
to  each  and  every   organ 
Normal 
6. Nagan Helps  in opening  and  closing  
of  eyelids 
Normal 
7. Koorman Responsible  for  vision,  
lacrimation  and   yawning 
Normal 
8. Kirugaran Induces  appetite,  salivation,  all  
secretions  in  the  body   
including   nasal  secretion  and  
sneezing 
Affect 
SIDDHA ASPECT 
SOMBU THEENEER FOR SWASAKAASAM  Page 18 
9. Thevathathan 
 
Induces  and  stimulates  a  
person  to  become   alert,  get  
anger  to quarrel  to  sleep etc. 
Affect 
10. Dhananjeyan Resides  in  the  cranium  and  
produces  bloating  of  the  body  
after  death. This  leaves  from  
the  body  after  3days  of  death  
forming  a  way  through  the  
skull. 
_ 
 
In SwasakasamPrananan, Kirugaran  andDevathathan  will be  mainly  affected
23
. 
FUNCTIONS OF AZHAL: 
“                               
                   -     
                            
                ” 
-                    
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S.NO PITHAM NORMAL   FEATURES CHANGES  IN  
SWASAKASAM 
1. Anarpitham Peps up the appetite  and  aids  
in digestion. 
Normal 
2. Ranjagapitham Responsible for the color and  
contents  of blood . 
Normal 
3. Sathagapitham Controls  the  whole  body  
and  is  held  responsible  for  
fulfilling  a  purpose. 
Affect 
4. Pirasagapitham Dwells  in the  skin  and  
concerned  with the  shine  
glow  texture  and its  
complexion. 
Normal 
5. Alosagapitham Responsible for the perception  
of vision
.
 
Normal 
 
In Swasakasam , Sathagapitham  will  be  mainly  affected. 
FUNCTIONS OF IYAM: 
“                             
                    –      
                             
                    ” 
-                
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S.NO KABAM GENERAL    FEATURES CHANGES   IN   
SWASAKASAM 
1. Avalambagam Lies  in  the  respiratory  
organs,  exercises  authority  
over  other  khabhas  and  
controls  the  heart  and  
circulatory system. 
Affect 
 
2. 
Kilethagam Found  in  stomach  as  its  seat, 
moistens  the food , softens  and  
helps  to  be  digested. 
Normal 
3. Pothagam Hold responsible for  the 
sensory  perception  of  taste. 
Normal 
4. Tharpagam Presents  in the  head  and  is  
responsible  for  the  coolness  
of  the  eyes, sometimes  may  
be  referred  to  as  
cerebrospinal  fluid. 
Normal 
5. Santhigam Necessary for  the lubrication  
and the  free  movement  of  
joints
21
. 
Normal 
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UDAL   KOORUGAL (SEVEN PHYSICAL CONSTITUENTS): 
“                                             
                                         
                                          
                                          
           ” 
-                     
S.NO UDAL  KATTUGAL GENERAL   FEATURES CHANGES  IN  
SWASAKASAM 
1. Saaram (digestive  
essence) 
Responsible for the growth  
&development. It  keeps  the  
individual  in  good  
temperament  and  it  enriches  
the  blood. 
Affect 
2. Senneer (Blood) Responsible  for  the  colour  
of blood  and  for  the  
intellect, nourishment, 
strength, vigour  and  valour  
of  the  body. 
Affect 
3. Oon (Muscle) Gives  notable  contour  to  
the  body  as  needed  for  the  
physical  activity. It  feed  the  
fat  next  day  and  gives  a 
sort  of  plumpness  to  the  
body. 
Normal 
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4. 
 
Kozhuppu (Fat) Lubricates the organs to 
facilitate frictionless 
functions. 
Normal 
5. Enbu (Bones) Supports  and  protects  the  
vital  organs, gives  the  
definite  structure  to  the  
body  and  responsible  for  
the  posture  and  movements  
of  the body. 
Normal 
6. Moolai (Bone marrow) Nourishes  the bone marrow  
and  brain  which  is  the  
centre  that  controls  other  
systems  of  body. 
Normal 
7. Sukkilam/Suronitham 
(Sperm/Ova) 
Responsible  for  
reproduction 
Normal 
 
In Swasakasam , Saaram  and  Senneer  will be affected. 
KAALA MARUBADUGAL: 
PARUVAKALAM (SEASONS): 
According  to  ancient  tamilians, a year  is  divided  into  six  seasons  and 
each  season  consists of  two  months  and  the year  starts  from  Margazhi. 
S.NO KAALAM TAMIL 
MONTHS 
MUKKUTTRA  
MARUPAADUGAL 
1. Kaar Kaalam Aavani & 
Purattasi 
Aug 16  To  
Oct 15 
VATHAM – Vetrunilai 
Valarchi 
PITHAM   - Thanilai 
valarchi 
2. Koothir 
Kaalam 
Iypasi & 
Karthigai 
VATHAM – Thanilai 
Valarchi 
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Oct 16   To  
Dec 15 
PITHAM   - Vetrunilai 
Valarchi 
3. Munpani 
Kaalam 
Margzhi &  
Thai 
Dec 16  To  
Feb 15 
PITHAM  - Thanilai 
Valarchi 
4. Pinpani 
Kaalam 
Masi & 
Panguni 
Feb 16  To  
April 15 
KABAM  - Thanilai 
Valarchi 
5. Elavenir 
Kaalam 
Chithrai & 
Vaikasi 
April 16  To  
June 15 
KABAM  - 
VetrunilaiValarchi 
6. Mudhuvenir 
Kaalam 
Aani & Aadi 
June 16  To  
Aug 15 
VATHAM – Thanilai 
Valarchi 
 
Swasakasam  is  more  prevalent  in Pinpani  and  Elavenir Kaalam  due  to  
vitiation  of  Kabham. 
THENAI (LAND):  
Siddhars classified the lands  into  five  types. They are, 
 Kurunchi     - Mountain range 
 Mullai         - Pastoral  area  of  the  forest 
 Marudham  -  The  fertile  river  bed 
 Neidhal       - The coastal  region 
 Paalai          - Arid  desert  
 
Prevalence of the disease Swasakasam is more comman in Kurunchi and 
Paalainilam. Pitha disease occurs in Mullailand. Vadha disease occurs in 
Neidhal land. Marudham land is the fertile area where no disease will occurs
25
. 
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RELATIONS BETWEEN MUKKUTRAM, KAALANGAL AND 
THINNAIGAL: 
PARUVAKAALAM (SEASONS) 
MUKKUTRAM Thannilai 
Vazharchi 
(Accumulation) 
Vetrunilai 
Vazharchi 
(Aggravation) 
Thannilai 
Adaithal 
(Alleviation) 
THINAI 
VATHAM Mudhuvenil 
kaalam 
Kaar 
kaalam 
Koothir 
kaaalam 
Vatha  disease  is 
more  prevalent  
in NEIDHAL  
land 
PITHAM Kaar 
kaalam 
Koothir 
kaaalam 
Munpani Pitha  disease  is  
more  prevalent  
in  MULLAI 
land 
KAPHAM Pinpani Elavenil 
kaalam 
Mudhuvenil 
kaalam 
Kapha  disease  
is  more  
prevalent  in  
KURUNCHI 
land 
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PINIYARI MURAIMAI (DIAGNOSIS): 
“                  
                     
                 
                    
               
                  
               
                     .” 
-                 
Four steps are followed in diagnosing the disease. They are, 
i) Poriyaalarithal 
ii) Pulanaaltherthal 
iii) Vinaathal 
iv) Envagaithervu 
In detail, 
i) Poriyaalarithal: 
 In  this  the  physician  should  carefully  observe  the  changes  that  occur  in  
the  five  sensory  organs [Porigal]  of  the patient. 
ii) Pulanaaltherthal: 
 The physician  carefully applies  his  five  senses  of  perception,  smell,  taste,  
vision,  touch,  and  sound  to understand  the  condition  of the  patient. 
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iii) Vinaathal: 
The  physician  should interrogate  about  the  patients  name,  age,  
occupation,  socio economic status,  food habits,  history  of  past  illness,  
history  of  present illness,  family history,  martial status,  menstrual history  
and  frequency  of  pain. 
iv) Ennvagai  thervukal: 
Siddhars  have  developed  a  unique  method  of  diagnosing  the  disease  by 
“EnvagaiThervugal”16. 
“                           
                       ” 
          -                        
. 
The diagnosis is made  based  on  the  following: 
 Naa 
 Niram 
 Mozhi 
 Vizhi 
 Malam 
 Moothiram 
 Naadi 
 Sparisam 
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1. NAA: 
Signs and symptoms in the tongue  are  noted  here. Colour, Salivary 
secretion,  ulcers,  coating,  inflammation,  taste changes,  deviation  and  its  
nature  are  generally  noted. In  Swasakasam,  naa  will  be  affected  due  to  
dryness  of  tongue. 
2. NIRAM: 
The colour  of  the  skin  is  noted  here.In  Swasakasam, niram  will  
be  normal. 
3. MOZHI: 
Character  of  the  speech  is  noted,  mainly  urathaolli(high  pitched), 
thazhnthaolli(low  pitched),  or  resembles  the  sound  of  any  instrument.In  
Swasakasam, mozhi  will be  affected  due  to  breathlessness. 
4. VIZHI: 
Character of the eye is noted. Color, warm, burning sensation, 
irritation, visual perception. In  Swasakasam, vizhi will be normal. 
5. MALAM: 
The  stools  are examined  for  quantity, hardening(malakattu),loose  
motion(bethi), colour  and  smell. In  Swasakasam, malam will be normal. 
 
6. MOOTHORAM: 
 
i) NEERKURI: 
 The urine is examined for its colour, odour, volume, froth, and weight. 
In Swasakasam, moothiram will be normal. 
ii) NEIKURI: 
  “                         
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                            ”  
-                    
The  early  morning  urine  of  the patient  is  analysed  by  dropping  a  
drop  of  gingley oil  on  the  surface  of  the   urine  sample. The 
accumulation, formation, changes, and dispersal  under  the  sunlight  without  
any  external  disturbances  of  the  urine sample  should  be  noted
22
. 
 Vathaneer – The oil  spreads  like  snake 
 Pithaneer    - The  oil  spreads  like  ring 
 Kabhaneer - The  oil  spreads  like  pearl 
 If  the  oil  spreads  gradually,  it  indicates  good  prognosis 
 If  the  oil  spreads  fast  or  gets  mixed  completely  with  urine  or  sinks  in  
urine, it  suggests  bad  prognosis
22
. 
Since Swasakasam is  due  to  the  derangement  of  vatham  and  kapham, the      
neikuri  will be  vatha  or  kabhaneer. 
7. NAADI: 
 Naadi  is  a  unique Siddha  Pulse  reading  method  and  it  should  be  felt  
and  not read. Different gaits of Vazhi, Azhal, Iyam like branching, jumping, 
mixing, rotating and compression can be identified. 
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NAADINADAI: 
IDENTIFICATION 
(FINGER) 
INDEX MIDDLE RING 
STRENGTH (IN  UNIT) 1 1/2 ¼ 
PATTERN MALE HEN TORTOISE SNAKE 
 FEMALE SNAKE FROG SWAN 
 
8. PARISAM: 
Observation such as touch, temperature, sensory impairment, masses, nodes, 
swelling and texture of the skin, pain, hardness, oedematous, and dullness 
shall be noted. In Swasakasam, the patient’s body may be either heat or cold. 
LINE OF TREATMENT 
In  Siddha  system, the  main  aim  of  the  treatment  is  to  cure  udalnoi and  
mananoi. Treatment  is  given  not  only  for   complete  healing  but  also  for  
the  prevention  and   rejuvenation. It consist  of 
 Kaapu (Prevention) 
 Neekam (Treatment) 
 Niraivu (Reastoration) 
1. MEDICINE: 
 SOMBU THEENEER - 15ml with 30ml of warm water, twice daily. 
2. ADVICE: 
 To  follow  good  personal  hygiene 
 Avoid chill and cold weather 
 To find  out  allergens  and  avoid  them 
 To avoid  exposure  to  dust, Fumes  and  smokes 
 To  avoid   smoking 
 Advised  to  practice  pranayamam  and  asanas 
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3. YOGA  PRACTICE: 
 Yogasanas  are  designed  to  promote  a  state   of  mental  and  
physical  wellbeing. It consists of relaxation, breathing exercise and physical 
posture. In can help circulation and breathing, posture and hormonal balance. 
They will improve the strength of the muscles  involved  in  respiration. 
 Pranayama 
 Pujangasanam 
 Patchimotasana 
 Salabasana 
 Machasana. 
PRANAYAMAM 
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ASANAS FOR BRONCHIAL ASTHMA 
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MODERN ASPECT 
ANATOMY AND PHYSIOLOGY OF RESPIRATORY SYSTEM: 
              Developmentally the respiratory system is an outgrowth from the 
ventral wall of the foregut .The organs of the respiratory system are nose, 
pharynx, larynx, trachea, two bronchi(one bronchus to each lung), bronchioles 
and smaller air passages, two lungs and their coverings- the pleura, muscles of 
respiration –the intercostal muscles and the diaphragm. The upper respiratory 
tract includes the nose, naso-pharynx and larynx. It is lined by vascular 
mucous membranes with ciliated epithelium on their surfaces. 
 The lower respiratory tract includes the trachea and bronchi. These 
form an inter connecting tree of the conducting airways eventually joining, via 
around 64000 terminal bronchioles, with the alveoli to form the acini. The 
lower respiratory tract is lined with ciliated epithelium as far as the terminal 
bronchioles.
35 
TRACHEA: 
 The trachea is a wide tube lying more or less in midline, in the lower 
part of the neck, which serves to conduct air to both lungs for respiration. It 
starts at the lower border of the cricoid cartilage and ends at the level of the 
upper border of the thoracic vertebra by dividing into two bronchi, right and 
left. 
FUNCTIONS: 
 Support and patency 
 Muco-ciliary escalator 
 Cough reflex 
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ARTERIAL SUPPLY: 
Inferior thyroid arteries 
VENOUS DRAINAGE:  
             Into the left brachio-cephalic vein 
LYMPHATIC DRAINAGE: 
            To the  pretracheal and paratracheal nodes. 
BRONCHI: 
 The two bronchi are formed when the trachea divides, i.e at the level of 
the 4
th
 thoracic vertebra. The right bronchus is a wider, shorter tube than the 
left bronchus and it lies in a more vertical position. After entering the right 
lung at the hilum, it divides into three branches, one of which passes to each 
lobe. Each branches then subdivided into numerous smaller branches. The left 
bronchus is narrower than the right. After entering the left lung at the hilum, it 
divides into two branches, one of which goes to each lobe. Each branch then 
subdivides progressively into smaller tubes within the lung substance. 
FUNCTIONS: 
 Warming and humidifying 
 Support and patency 
 Removal of particulate matter 
 Cough reflex 
LUNGS: 
 The lungs are indegeniously constructed to carry out their cardinal 
function i.e. the exchange of gases between inspired air and blood. The lungs 
are pair of respiratory organs situated in the thoracic cavity. They are spongy 
in texture. In the young the lungs are brown or grey in colour. Gradually they 
become mottled black because of the deposition of inhaled carbon particles.
37 
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LOBES AND FISSURES: 
RIGHT LUNG: 
 The right lung is slightly larger than the left is divided by the oblique 
and horizontal fissures into three lobes, the upper, middle and lower lobes. 
LEFT LUNG: 
 The left lung is divided by a similar oblique fissure into lobes. The 
upper and the lower lobes. There is no horizontal fissure in the left lung. The 
Broncho pulmonary segments are the anatomical, functional and surgical units 
of the lungs. Each lobar bronchus which passes to a lobe of the lung gives off 
branches called segmental bronchi .Each segmental bronchus then enters a 
Broncho pulmonary segment. The main Broncho pulmonary segments are as 
follows: 
RIGHT LUNG 
SUPERIOR LOBE 
 Apical 
 Posterior 
 Anterior 
MIDDLE LOBE 
 Lateral 
 Middle 
INFERIOR LOBE 
 Superior(Apical) 
 Medial Basal 
 Anterior Basal 
 Lateral Basal 
 Posterior Basal 
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LEFT LUNG 
SUPERIOR LOBE 
 Apical 
 Posterior 
 Anterior 
 Superior Lingual 
 Inferior Lingula 
INFERIOR LOBE 
 Superior (Apical) 
 Medial Basal 
 Anterior Basal 
 Lateral Basal 
 Posterior Basal 
ROOT OF THE LUNG: 
           Root of the lung is a short, broad pedicle which connects the medial 
surface of the lung to the mediastinum. It is formed by structures which either 
enter or come out of the lung at the hilum (latin depression). The roots of the 
lung lie opposite the bodies of the fifth, sixth and seven thoracic vertebrae. 
CONTENTS: 
The root is made up of the following structures. 
1. Principle bronchus on the left side, and eparterial and hypaterial bronchi on 
the right side. 
2. One pulmonary artery. 
3. Two pulmonary veins, superior and inferior. 
4. Bronchial arteries, one on the right side and two on the left side. 
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5. Bronchial veins.
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6. Anterior and posterior pulmonary plexuses of nerves. 
7. Lymphatics of the lung. 
8. Broncho pulmonary lymph nodes. 
9. Areolar tissue. 
BLOOD SUPPLY: 
The bronchial arteries supply nutrition to the bronchial tree and to the 
pulmonary tissue. These are small arteries that vary in number, size and origin, 
but usually they are as follows; 
 On the right side, there is one bronchial artery which arises from the 
third right posterior intercostal artery. 
 On the left side, there are two bronchial arteries both of which arise 
from the descending thoracic aorta. 
Deoxygenated blood is brought to the lungs by the two pulmonary 
arteries and oxygenated blood is returned to the heart by the four pulmonary 
veins. 
VENOUS DRAINAGE: 
 The venous blood from the first and second divisions of the bronchi is 
carried by bronchial veins. Usually there are two bronchial veins on each side. 
 The right bronchial veins drain into the azygos vein. 
 The left bronchial veins drain into the hemiazygos vein. 
The greater part of the venous blood from the lungs is drained by the 
pulmonary vein
29
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LYMPHATIC DRAINAGE: 
 There are two sets of lymphatics, both of which drain into the 
bronchopulmonary nodes.  
1. Superficial vessels drain the peripheral lung tissue lying beneath the 
pulmonary pleura. The vessels pass round the borders of the lung and 
margins of the fissure to reach the hilum. 
2. Deep lymphatics drain the bronchial tree, the pulmonary vessels and 
the connective septa. They run towards the hilum where they drain into 
the bronchopulmonary node. 
3. The superficial and deep lymph vessels communicate with each other. 
NERVE SUPPLY: 
1. Parasympathetic nerves are derived from vagus. These fibers are 
a. Motor to the bronchial muscles and on stimulation cause 
bronchospasm. 
b. Secretomotor to the mucous glands of the bronchial tree. 
c. Sensory fibres are responsible for the stretch reflex of the lungs, 
and for the  cough reflex
32
. 
2. Sympathetic nerves are derived from second to fifth sympathetic 
ganglia. These are inhibitory to the smooth muscle and glands to the 
bronchial tree. That is how sympathomimetic drugs, like adrenalin, 
cause broncho dilatation and relieve symptoms of bronchial asthma. 
RESPIRATORY UNIT: 
 Respiratory unit is the terminal portion of respiratory tract. The 
exchange of gases occurs only in this part. It starts from the respiratory 
bronchioles. Each respiratory bronchiole divides into alveolar ducts. Each 
alveolar ducts enters an enlarged structure called alveolar sac. The space inside 
the alveolar sac is called antrum. The wall of the antral sac contains the 
alveoli.
41 
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RESPIRATORY MEMBRANE: 
 Respiratory membrane is the membranous structure through which the 
exchange of gases occurs. The blood vessels in the lungs form a capillary 
network beyond the terminal bronchiole. The capillaries are formed by 
endothelial cells. The alveolar membrane and the capillary membrane together 
form the respiratory membrane. The respiratory membrane separates air in the 
alveoli from the blood in capillary. Respiratory membrane has a surface area 
of 70 sq. meters and thickness of 0.5 microns. 
DEFENCE MECHANISM IN THE LUNGS 
 The dust particles, which enter the nostrils, are prevented from 
reaching the lungs by filteration action of the hairs in the mucus membrane. 
The small particles, which escape the hairs, are held by the mucus secreted by 
the nasal mucous membrane. Those dust particles, which escape the nasal 
hairs and nasal mucous membrane, are removed by the phagocytic action of 
the macrophages in the alveoli. The particles which escapes the protective 
mechanisms in nose and alveoli are thrown out by cough and sneezing reflex. 
1. LUNGS OWN DEFENCES: 
 The epithelial cells lining the air passage secrete some innate immune 
factors called defencins and cathelicidins. These substances are the 
antimicrobial peptides which play an important role in lungs own defences. 
2. LEUKOCYTES: 
 The leukocytes, particularly the neutrophils and lymphocytes present 
in the alveoli of lungs play their role in the defense mechanism against 
bacteria and virus. The neutrophils kill the bacteria by phagocytosis. 
Lymphocytes are responsible from the development of immunity against 
bacteria. 
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3. MACROPHAGES: 
             Macrophages engulf the dust particles and pathogens, which enter the 
alveoli and thereby acts as scavengers in lungs. Macrophages are also involved 
in the development of immunity by functioning as antigen presenting cells. 
When foreign organisms invade the body, the macrophages and other antigen 
presenting cells kill them. Later the antigen from the organisms is digested to 
polypeptides. The polypeptide products are presented to T lymphocytes and B 
lymphocytes by the macrophages. Macrophages secrete interleukins, tumour 
necrosis factors and chemokines. Interleukins and TMF activate the general 
immunity system of the body. Chemokines attract the white blood cells 
towards the site of inflammation. 
4. MAST CELL: 
 Mast cell is a large tissue resembling the basophil. It produces the 
hypersensitivity reactions like allergy and anaphylaxis. It secretes heparin, 
histamine, serotonin and hydrolytic enzymes. 
5. NATURAL KILLER CELLS (NK) 
 Natural killer cell is a large granular cell, considered as the third type 
of lymphocyte. Usually NK cell is present in lumgs and lymphoid organs. Its 
granules contain hydrolytic enzymes, which destroy the microorganisms. NK 
is said to be the first line of defence in specific immunity particularly against 
viruses. 
6. DENTRITIC CELLS: 
 Dendritic cells in the lungs play important role in immunity. Along 
with macrophages, these cells function as antigen presenting cells
40
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RESTRICTIVE AND OBSTRUCTIVE RESPIRATORY DISEASES: 
The diseases of the respiratory tract are classified into two types: 
1. Restrictive respiratory disease 
2. Obstructive respiratory disease 
               These two types of respiratory diseases are determined by lung 
function tests, particularly FEV. In restrictive diseases, the PEFR is 
200litres/min and in obstructive disease, it is only  100litre/min. Hence, the 
reduction is more significant in obstructive diseases than in restrictive 
diseases
41
. 
RESTRICTIVE RESPIRATORY DISEASE  
              Any abnormal respiratory condition, which makes it difficult to get 
the air into the lungs (inspiration) is called restrictive respiratory disease. The 
expiration is not affected. Restrictive respiratory disease may be because of 
abnormality of lungs, thoracic cavity or nervous system. Some of the 
restrictive respiratory diseases are, 
 Polio 
 Myasthenia gravis 
 Flial chest 
 Paralysis of diaphragm 
 Pleural effusion 
OBSTRUCTIVE RESPIRATORY DISEASE 
              Any abnormal respiratory condition, which makes it to difficult to 
push the air outside the lungs (expiration) is called Obstructive respiratory 
disease. Some of the Obstructive respiratory diseases are, 
 Bronchial asthma 
 Chronic bronchitis 
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 Emphysema 
 Cystic fibrosis 
BRONCHIAL ASTHMA 
DEFNITION: 
              Bronchial asthma is characterised by chronic airway inflammation 
and increased airway hyper-responsiveness leading to symptoms of wheeze, 
cough, chest tightness, and dyspnoea. It is characterised functionally by the 
presence of airflow obstruction which is variable over short periods of time, or 
is reversible with treatment.
38 
EPIDEMOLOGY: 
            The prevalence of asthma increased steadily over later part of the last 
century in countries with western lifestyle and is also increasing in developing 
countries. Current estimates suggest that 300 million people world-wide suffer 
from asthma and an additional100 million may be diagnosed with asthma by 
2025. In childhood, asthma is more common in boys, but following puberty 
females are more frequently affected. The socio-economic impact of asthma is 
enormous, particularly when poor control leads to days lost from school or 
work, hospital admission and for some patients, a premature death
42
. 
TYPES: 
             Based on the stimuli initiating bronchial asthma, two broad aetologic 
types are described 
1. Extrinsic (allergy, atopic) 
2. Intrinsic (Idiosyncratic, non-atopic) 
ATOPIC OR ALLERGIC ASTHMA 
              This most common type of asthma usually begins in childhood. The 
disease is triggered by environmental antigens such as dusts, pollens, animal 
dander and foods, but potentially any antigen is implicated. A positive family 
history of atopy is common and asthmatic attacks are often preceded by 
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allergic rhinitis, urticarial or aczema, serum IgE levels are raised. A skin test 
with the offending antigen results in an immediate wheal and flare reaction, a 
classic example of type 1IgE mediated hypersensitivity reaction. 
 
NONATOPIC ASTHMA 
               The second large group is non atopic variety of asthma which is not 
frequently triggered by respiratory infections, viruses(eg Rhinovirus, 
parainfluenza virus) rather than bacteria are the most common provokers. A 
positive family history is uncommon, serum IgE levels are normal and there 
are no other associated allergies. In these patients skin test results are usually 
negative and although hypersensitivity to microbial antigens may play a role, 
present theories play more stress on hyperirritability of the bronchial tree. It is 
although that virus induced inflammation of the respiratory mucosa lowers the 
threshold of the subepitheial vagal receptors to irritants. Inhaled air pollutants 
such as SO2, Ozone and nitrogen dioxide may also contribute to the chronic 
airway inflammation and hyper reactivity present in some cases. 
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DRUG INDUCED ASTHMA 
                Several pharmacological agents provoke asthma. Aspirin sensitive 
asthma is a somewhat fascinating type occurring in patients with recurrent 
rhinitis and nasal polyps. These individuals are exquisitely sensitive to very 
small doses of aspirin and they experience not only asthmatic attacks but also 
urticarial. It is probable that aspirin triggers asthma in those patients by 
inhibiting COX pathway of arachidonic acid metabolism without affecting 
LOX pathway thus tipping the balance towards elaboration of Broncho 
constrictor leukotrienes. 
OCCUPATIONAL ASTHMA 
                This form of asthma is stimulated by fumes (epoxy resins, plastics ) 
organic and chemical dusts (wood, cotton, platinum), gases (toluene) and other 
chemicals (formalin, penicillin products).Very minute quantities are required 
to induce the attack which usually occurs after repeated exposure. The 
underlying mechanisms vary according to stimulus and induced type IgE 
mediated reactions, direct liberation of Broncho constrictor substances and 
hypersensitivity responses of unknown origin
43
. 
PATHOPHYSIOLOGY 
 Chronic airway inflammation as evidenced by cellular infiltration of 
airways by activated eosinophils, mast cells, macrophages, and T-
lymphocytes 
 Released mediators from the above cells cause bronchial smooth 
muscle contraction 
 Denudation and desquamation of the epithelium forming mucous plugs 
that obstruct the airway 
 Airway remodelling is evidenced by  
i. Smooth muscle hypertrophy and hyperplasia 
ii. Goblet cell and sub-mucosal gland hypertrophy leading to mucous 
hypersecretion. 
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iii. Collagen deposition causing thickening of lamina reticularis 
iv. Cellular infiltration, oedema and possible airway wall thickening
44
 
FACTORS PRECIPTATING ASTHMA: 
 Cold air 
 Tobacco smoke 
 Dust, acrid fumes 
 Emotional stress 
 Respiratory infections (Viral, bacterial) 
 Exercise 
 Drugs 
i) NSAIDs especially aspirin 
ii) β-blockers 
 Chemicals 
Sulphating agents like Na or K bisulphate, Sulphur dioxide etc. 
 Allergens 
i. Ingested ( fish, nuts, strawberries) 
ii. Inhaled (dust, pollen, house dust mite) 
iii. Food additives (atrazine, metabisufite preservatives, monosodium 
glutamate or ajino-moto) 
iv. Occupational allergens (grain-dust, wood-dust)45 
CLINICAL FEATURES: 
 
 Wheezing 
 Widespread polyphonic, high pitched wheezes are heard. 
 Expiratory wheeze is heard with mild Broncho-constriction 
 Inspiratory and expiratory wheezes are heard in moderate Broncho-
constriction. 
 Inspiratory wheeze is heard in severe Broncho-constriction 
 In near fatal asthma, the chest is silent. 
 Chest tightness 
 Breathlessness 
 Cough with mucoid tenacious sputum46 
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NOCTURNAL ASTHMA: 
            Nocturnal asthma is defined as an overnight fall of more than 20% in 
the FEV1 or PEFR it may the sole manifestation of asthma. This is presumed 
due to: 
i. Early morning fall in circulating, adrenaline. 
ii. Overnight change in vagal tone (increased vagal tone in the morning). 
iii. Airway cooling at night. 
iv. Circulation changes in plasma cortisol concentration (midnight to early 
morning fall in cortisol level). 
GASTRIC ASTHMA: 
               Worsening of asthma after meals or dyspnea occurring only after 
meals is due to gastro-esophageal reflux. This is treated by avoiding oral 
bronchodilators and instituting anti reflux therapy. 
EXERCISE INDUCED ASTHMA: 
            Asthma is induced by exercise and inhaled bronchodilators should be 
given before exercise. Usual therapy is with pre exercise bronchodilators or 
sodium-chromoglycate. 
EPISODIC ASTHMA: 
           Patient has no respiratory symptoms between episodes of asthma. 
CHRONIC ASTHMA: 
    Symptoms may be chronic unless controlled by appropriate therapy. It 
may stimulate chronic bronchitis. 
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CLASSIFICATION OF SEVERITY: 
 SYMPTOMS NIGHT 
TIME -
SYMPTOMS 
PEF 
Step 1 
Intermittent 
<1 time a week 
Asymptomatic and 
normal PEF between 
attacks 
≤ 2times a 
month 
≥ 80% predicted 
variability <20% 
Step 2 
Mild persistent 
≥ 1 time a week but < 1 
time a day 
>2 times a 
month 
≥ 80% predicted 
variability <20-
30% 
Step 3 
Moderate 
persistent 
Daily use β2 agonist, 
daily attacks affect 
activity 
>1 time a 
week 
<80% predicted 
variability >30% 
Step 4 
Severe persistent 
Continuous limited 
physical activity 
Frequent ≤ 60% predicted 
Variability >30% 
 
ACUTE SEVERE ASTHMA (STATUS ASTHMATICUS) 
     It is a medical emergency. Patient is hypoxic and cyanosed due to 
severe bronchospasm. It is characterized by tachycardia (pulse rate > 120), 
tachypnea (respiratory rate > 30/min), sweating, pulsusparadoxus, altered level 
of consciousness, and inspiration- expiration ratio 1:3 or 1: 4.
46 
Life threatening features: 
 Patient cannot speak 
 Central cyanosis 
 Exhaustion, confusion, altered consciousness 
 Bradycardia 
 Silent chest 
 Unrecordable peak flow 
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 Severe hypoxaemia (8 kpa) 
 A normal or high co2 tension (5-6 kpa) 
 A low ph or high H+. 
DIAGNOSIS AND SPECIAL INVESTIGATION: 
Blood 
 Slight eosinophilia is present but the absolute count is less than 1000/mm3 
other blood changes are elevated IgE. 
Sputum 
 It shows eosinophils, charcotleyden crystals, crucians spirals and 
Laennec’s pearls and creoles bodies apart from infective agents. 
X-ray Chest 
 It shows over inflation of lungs in acute attack but may show 
emphysematous changes in late stages. 
Pulmonary function test 
 The degree of airway obstruction can be measured by FEV1 and 
FEV1/FVC ratio both of which are reduced and improves after the use of 
bronchodilators. The diffusing capacity is usually normal. 
Blood gas analysis 
 It shows diminished po2 and raised paco2 in status asthmaticus but normal 
in mild attacks. In earlier states respiratory alkalosis is present but in severe 
late stages respiratory acidosis results. 
Skin tests 
 By pricking test hypersensitivity reaction to various antigens can be 
obtained 
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ECG 
 It shows normal features except tachycardia. But sometimes P.pulmonale, 
Right axis or RBBB pattern may be observed 
COMPLICATION 
 Status asthmatics 
 Secondary infection-bronchitis, tuberculosis 
 Emphysema of lungs 
 Right heart failure in late stages called chronic corpulmonale 
 Bronchiectasis 
 Pneumothorax, pneumo mediastinum 
     DIFFERENTIAL DIAGNOSIS: 
1. Chronic bronchitis 
2. Emphysema 
3. Cystic fibrosis 
4. Cardiac failure 
5. Allergic Broncho-pulmonary aspergillosis. 
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TRIAL DRUG 
PREPARATION AND PROPERTIES OF TRIAL MEDICINE 
SOMBU THEENEER 
INGREDIENTS: 
 Sombu  - 300 gms 
 Water    - 10 litres 
STANDARD OPERATIVE PROCEDURE 
SOURCE OF RAW DRUGS: 
               The required raw drugs are procured from a well reputed indigenous drug 
shop. The raw drugs taken for study will be authenticated by the Pharmacognosist of 
Siddha Central Research Institute, Chennai. 
PREPARATION: 
The above said drug Sombu is grounded coarsely and immersed in water for 
about 8hrs then it is distillate into the distillation apparatus finally 5 litres of 
THEENEER is collected. 
DRUG STORAGE: 
The trial drug is stored in clean dry air tight container and it is given to the 
patients in diluted form. 
DOSAGE: 
30 – 60 ml with equal quantity of water twice daily 
DURATION: 
30 days 
REFERENCE-SIDDHA VAITHIYA THIRTTU 
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REVIEW OF LITERATURE FOR TRIAL MEDICINE 
ச ோம்பின் பபோதுகுணம்: 
ச ோனிச ோய் குன்மம் உரூட்ச மந் தம்பபோருமல்  
 சபனமுறு கோ ம் பீலிகமிசைப் - பீனஉசை 
ச ர்க்கின்ற வோதமுசபோஞ் ரீ்பபரி  ைீகத்தோல் 
 மூக்குச ோ ில்சல பமோழி. 
     - அகத்தி ர் குணவோகடம். 
MEDICINAL USES : 
It is given to cure Asthma, Fever, indigestion, Liver diseases, cough, rhinitis, 
abdominal pain.
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INGREDIENT OF SOMBU THEENEER 
SOMBU – Pimpenella anisum 
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TRIAL MEDICINE 
SOMBU THEENEER 
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MATERIALS AND METHODS 
STUDY DESIGN:  
 The open clinical trial on SWASA KASAM was conducted at the OPD section 
of POST GRADUATE, MARUTHUVAM DEPARTMENT attached to ARIGNAR 
ANNA HOSPITAL OF INDIAN MEDICINE, Chennai-106 during the period 2015-
2017. 
POPULATION AND SAMPLE: 
 The population consists of all patients satisfying the inclusion and exclusion 
criteria mentioned below. Sample consists of Swasakasam patients attending the OPD 
of Arignar Anna Hospital, Arumbakkam, Chennai-106. 
SAMPLE SIZE: 
 The sample size will be 40 patients. 
INCLUSION CRITERIA: 
 Age: between 13-60years.  
 Symptoms of Bronchial asthma-breathlessness, cough, wheeze and 
chest tightness. 
 Willing to give specimen of blood for investigation when required. 
 Willing to attend the OPD once in 7 days. 
 Willing to participate in the trial and sign in consent form. 
EXCLUSION CRITERIA: 
 Status asthmatics 
 Drug induced bronchospasm (beta blockers and NSAIDS) 
 History of congestive cardiac failure 
 History of Bronchiectasis 
 History of Bronchogenic carcinoma 
 Chronic bronchitis 
 Vulnerable population like Pregnant and Lactating women, HIV 
Positive individuals, Diabetic and TB individuals. 
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WITHDRAWAL CRITERIA: 
 Intolerance to the drug and development of any serious adverse effect during 
the trial (If ADR     is reported the patient will be directed to RPC) 
 Patient turned unwilling to continue in the course of clinical trial  
 Poor compliance 
 Any other acute illness which need rescue medication. 
EVALUATION OF CLINICAL PARAMETERS: 
Patients are clinically evaluated using following parameters. 
HISTORY TAKING: 
Age, occupation, socio economic status, complaints and duration, previous 
illness, family history, Personal habits were recorded in the case sheet for 
every patient during his/her first visit to OP. 
INVESTIGATIONS: 
BLOOD: 
 TC 
 DC 
 ESR 
 Hb 
 Blood Sugar (F) & (PP) 
 Blood Urea 
 Serum Cholesterol 
URINE: 
 Albumin 
 Sugar 
 Deposits 
 X-ray Chest PA View 
 PEFR (peak expiratory flow rate) 
 Absolute eosinophil count. 
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CLINICAL DIAGNOSIS BASED ON SIDDHA SYSTEM: 
 The parameters used to diagnosis the disease Swasa kasam based on Siddha 
system are: 
 Poriaalaridhal 
 Pulanaalaridhal 
 Vinaadhal 
 Uyirthathukkal 
 Udalthaukkal 
 Envagaithervu 
   Naa, Niram, Mozhi, Vizhi, Sparisam, Malam, 
Moorthiram, Naadi. 
 Neerkuri: 
Niram, Manam, Nurai, Enjal, Edai 
 Neikuri 
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RESULTS AND OBSERVATION 
 
The study on Swasakasam was carried out in 40 patients in the Department 
of Pothumaruthuvam, Government  Siddha  medical College, Chennai-106 
attached to Arignar Anna Hospital during 2015-2017 were analysed. The 
observation were made and tabulated with following criteria. 
 
 Sex Distribution 
 Age Distribution 
 Socio-Economic status 
 Occupational Reference 
 Personal habits Distribution 
 Diet Distribution 
 Kaalam Distribution 
 Paruvakaalam Distribution 
 Thinai Reference 
 Duration of illness 
 Mukkutram 
 Ezhu udal kattugal Reference 
 Envagai Thervugal Reference 
 Neikuri Reference 
 Clinical features 
 Clinical Prognosis 
 Peak Expiratory flow Rate 
 Grading of results. 
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1. SEX DISTRIBUTION: 
 
Sex No of cases / 40 Percentage 
 
Male 
 
17 
 
42.5% 
 
Female 
 
23 
 
57.5% 
 
 
 
 
Inference: 
 Out of 40 patients, 17 cases (42.5%) were male and 23 cases 
(57.5%) were female.  
 
 
 
 
Male 
42.5% 
Female 
57.5% 
SEX DISTRIBUTION 
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2. AGE DISTRIBUTION: 
 
 
 
 
 
 
 
 
Inference: 
              From selected 40cases, 3 patients (7.5%) were below 20 yrs,4 patients 
(10%) were between 21-30 yrs, 13 patients (32.5%) were between 31-40yrs, 
11 patients (27.5%) were between 41-50 yrs,9 patients (22.5%) were between 
51-60 yrs. 
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Age Distribution 
S. No Age Groups No of cases/40 Percentage (%) 
    1. Below 20 years 3 7.5% 
    2. 21-30 years 4 10% 
    3. 31-40 years 13 32.5% 
    4. 41 -50 years 11 27.5% 
    5. 50- 60 years 9 22.5% 
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3. SOCIO-ECONOMIC STATUS: 
S. No Socio-Economic Status/Annum No Of Cases Percentage (%) 
 
1. 
 
Poor (upto 200,000) 
 
23 
 
57.5% 
 
2. 
 
Middle class (200,000-500,000) 
 
9 
 
22.5% 
 
3. 
 
High class (Above 500,000) 
 
8 
 
20% 
 
 
 
 
Inference: 
Regarding the socio-economic status,23 patients (57.5%) comes under 
poor category,9 patients (22.5%) comes under middle category, and 8 patients 
(20%) comes under high class category. 
 
57.5% 22.5% 
20% 
SOCIO-ECONOMIC STATUS 
Poor Middle class High class
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4. OCCUPATIONAL REFERENCE: 
S. No Occupation No. Of Cases Percentage 
1. Business           3           7.5% 
2. Housewife           6           15% 
3. Traffic police            5           12.5% 
4. Student           3           7.5% 
5. Tailor           9           22.5% 
6. Office          14           35%     
 
 
 
  
 Inference: 
 Out of 40 patients, 3 patients (7.5%) were business man, 6patients 
(15%) were  housewife, 5 patient(12.5%)  was traffic policeman, 3 patient 
(7.5%) were student, 9 patient (22.5%) was tailor, 14 patient (35%) were 
office people. 
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5. PERSONAL HABIT REFRENCE: 
 
 
 
 
 
 
 
 
 
 Inference: 
 Regarding personal habits, 11 patients(27.5%) were smokers, 4 
patients(10%) were Alcoholic, 3 patients (7.5%) were , 1 patient (2.5%) was 
a snuff user. Remaining 21 patients(52.5%) were tee tootlers. 
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PERSONAL HABITS 
S. No Personal Habits & Diet No. Of Cases Percentage 
1. Smoking 11 27.5% 
2. Alcoholic 4 10% 
3. Both (Smoking & alcoholic) 3 7.5% 
4. Snuff 1 2.5% 
5. Others(Tee totallers) 21 52.5% 
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6. DIET REFRENCE: 
 
S. No Diet No. Of cases Percentage 
 
1. 
 
Vegetarian diet 
 
7 
 
17.5% 
 
2. 
 
Mixed diet 
            
33 
 
82.5% 
 
 
 
Inference: 
 Out of 40 patients, 7 patients (17.5%) have Vegetarian diet and 33 
patients (82.5%) have mixed diet. 
 
 
Vegetarian 
diet, 17.50% 
Mixed diet, 
82.50% 
DIET 
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7. KAALAM DISTRIBUTION: 
 
S.No Kaalam No. Of Cases / 40 Percentage (%) 
1. Valikaalam (0-33yrs)      15 37.5% 
2. Azhalkaalam(33-66yrs)      25 62.5% 
3. Iyyakaalam(66-100yrs)       -    - 
 
 
 
Inference: 
Out of 40 patients, 15 patients (37.5%) comes under Valikaalam, 25 
patients comes under Azhalkaalam. 
 
 
Vatha kaalam Pitha kaalam
37.50% 
62.50% 
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8. PARUVAKAALAM: 
S. No Paruvakaalam Months No.of Cases / 40 Percentage 
1. Kaarkaalam Avani, Puratasi, 
(Mid Aug- Mid Oct) 
        16 40% 
2. Koothirkaalam Iyppasi, Karthigai 
(Mid Oct - Mid Dec) 
         9 22.5% 
3. Munpani Margazhi ,Thai 
(Mid Dec – Mid Feb) 
         7 17.5% 
4. Pinpani Maasi,Panguni 
(Mid Feb- Mid April) 
         5 12.5% 
5. Elavenil Chithrai, Vaigasi 
(Mid April- Mid June) 
         2 5% 
6. Mudhuvenil Aani, Aadi 
(Mid June- Mid Aug) 
         1 2.5% 
 
 
Inference: 
 From selected 40 patients,16 patients(40%) comes under 
Kaarkaalam, 9 patients(22.5%) comes under Koothirkaalam,7 
patients(17.5%) comes under Munpani,5 patients (12.5%) comes under 
Pinpani, 2 patinets(5%) comes under Elavenil, 1patient (2.5%) comes 
under Mudhuvenil. 
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9. THINAI REFERENCE: 
 
 
 
 
Inference: 
Out of 40 patients,33 patients (82.5%) comes under Neidhal,7 patients 
(17.5%) comes under Marudham. 
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THINAI REFERENCE 
S. No Thinai No.of cases/40 Percentage 
1. Kurunji (Hill)        0 0% 
 2. Mullai (Forest)      0 0% 
3. Neidhal (Sea)     33  82.5% 
4. Marudham (Fertile)       7  17.5% 
5. Paalai (Desert)       0  0%     
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10. DURATION OF ILLNESS: 
S. No Duration of Illness No. of Cases Percentage 
1. Less than 1year 6 15% 
2. 1 year  - 5 years 25 62.5% 
3. 6 years – 10 years 5 12.5% 
4. More than 10years 4 10% 
 
 
 
Inference: 
 Out of 40 patients, 6 pateints(15%) belongs to less than one year duration, 25 
patients(62.5%) comes under 1-5 year duration, 5 patients(12.5%) comes under 6-
10year duration, and 4 patients (10%) have more than 10 years duration. 
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 11. REFERENCE TO MUKKUTRAM: 
I.VALI: 
S.No Classification of Vali No.of Cases Percentage 
1. Pranan              40 100% 
2. Abanan               5 12.5% 
3. Viyanan              35 87.5% 
4. Udhanan              40 100% 
5. Saamanan              14 35% 
6. Naagan               0 0% 
7. Koorman               3 7.5% 
8. Kirugaran              30 75% 
9. Devathathan              40 100% 
10. Dhanjeyan            0 0% 
 
 
 
 
 Inference: 
  From the selected 40 patients, Pranan was affected in 40 
patients (100%), Abanan was affected in 5 patients (12.5%), Viyanan was 
affected in 35 patients (87.5%),Samanan was affected in 14 patients 
(35%),Koorman was affected in3 patients(7.5%), Kirugaran was affected in 
30 patients (75%), Devathathan was affected in 40 patients (100%). 
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II: AZHAL: 
S.No Classification  of Azhal No. Of cases Percentage 
1. Analagam 14 35% 
2. Ranjagam 9 22.5% 
3. Saathagam 40 100% 
4. Aalosagam 3 7.5% 
5. Prasagam 0 0% 
 
 
Inference: 
Out of 40 patients, Analagam was affected in1 4 patients (35%), 
Ranjagam was affected in 9 patients (22.5%), Saathagam was affected in 40 
patients (100%), Aalosagam was affected in 3 patients (7.5%). 
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III. IYYAM: 
 
S.No Classification of Iyyam No. Of cases Percentage 
1. Avalambagam 40 100% 
2. Klethagam 14 35% 
3. Pothagam 0 0% 
4. Tharpagam 0 0% 
5. Santhigam 5 12.5% 
 
 
Inference: 
Out of 40 patients, Avalambagam was affected in 40 patients (100%), Klethagam was 
affected in 14 patients (35%), Santhigam was affected in 5 patients (12.5%). 
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12. EZHUUDALKATTUGAL: 
S. No Ezhuudalkattugal No. Of Cases Percentage 
1. Saaram 40 100% 
2. Seneer 9 22.5% 
3. Oon 0 0% 
4. Kozhuppu 0 0% 
5. Enbu 5 12.5% 
6. Moolai 0 0% 
7. Sukkilam/Suronitham 0 0% 
 
 
 
 Inference: 
Out of 40 cases, Saaram was affected in 40 patients(100%), Seneer 
was affected in 9 patients(22.5%), Enbu was affected in 5 patients(12.5%). 
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13. ENVAGAI THERVUGAL REFERENCE: 
S.No Envagai Thervugal No. Of Cases Percentage 
1. Naa 9 30% 
2. Niram 0 0% 
3. Mozhi 1 2.5% 
4. Vizhi 9 22.5% 
5. Sparisam 0 0% 
6. Malam 5 12.5% 
7. Moothiram 0 0% 
8. Naadi 40 100% 
 
 
Inference: 
Regarding Envagaithervu, Naa was affected in 9 patients(22.5%), 
Mozhi was affected in 1 patients(2.5%), Vizhi was affected in 9 
patients(22.5%), Malam was affected in 5 patients (12.5%), Naadi was 
affected in 40 patients(100%). 
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13. NAADI: 
 
S.No 
 
Naadi 
 
No. Of Cases 
 
Percentage 
 
1. 
 
KabhaVatha 
 
31 
 
77.5% 
 
2. 
 
VathaKabha 
 
9 
 
22.5% 
 
 
 
 
Inference: 
Out of 40 patients, 31 patients had Kabhavatha naadi and 9 patients 
had Vathakabha naadi. 
77.5% 
22.5% 
NAADI 
Kabha vatha Vatha kabha
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14. NEIKURI: 
 
S. No Neikuri Character of Urine No. Of cases Percentage 
1. Vathaneer Spreads like snake 9 22.5% 
2. Pithaneer Spreads like ring - - 
3. Kabhaneer Spreads like pearl 31 77.5% 
 
 
 
Inference: 
 Out of 40 patients, 9 patients (22.5%) had Vatha neer,31 patients 
(77.5%) had Kabha neer. 
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15. CLINICAL FEATURES: 
S. No Signs & Symptoms No. Of Cases Percentage 
1. Dyspnoea 40 100% 
2. Cough without expectoration 30 75% 
3. Wheezing 40 100% 
4. Tightness of chest 35 87.5% 
5. Rhinitis 6 15% 
6. Sneezing 6 15% 
7. Headache 4 10% 
8. Fever 0 0% 
9. Cyanosis 0 0% 
 
 
Inference: 
 Out of 40 patients, 40 patients(100%) had Dyspnoea, 30 patients (75%) had cough 
with expectoration, 40% patients (100%) had wheezing, 35 patients (87.5%) had 
tightness of chest, 6 patients (15%) had rhinitis, 6 patients (15%) had Sneezing, 4 
patients (10%) had headache. 
 
0%
20%
40%
60%
80%
100%
100% 
75% 
100% 87.50% 
15% 15% 10% 0 0 
CLINICAL FEATURES 
CLINICAL FEATURES
RESULTS AND OBSERVATION 
SOMBU THEENEER FOR SWASAKAASAM  Page 80 
16. CLINICAL PROGNOSIS: 
 
Inference: 
After treatment, Dyspnoea was present in 3 patients (7.5%), Wheezing 
was present in 3 patients (7.5%), Headache was present in 1patients (2.5%). 
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CLINICAL PROGNOSIS 
Before Treatment After Treatment
 
S. No 
 
Signs & Symptoms 
 
Before 
Treatment 
 
After 
Treatment 
 
No. Of 
Cases 
 
Percentage 
 
No. Of Cases 
 
Percentage 
1. Dyspnoea 40 100% 3 7.5% 
2. Cough without 
expectoration 
30 75% 0 0% 
3. Wheezing 40 100% 3 7.5% 
4. Tightness of chest 35 87.5% 0 0% 
5. Rhinitis 6 15% 0 0% 
6. Sneezing 6 15% 0 0% 
7. Headache 4 10% 1 2.5% 
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GRADING OF RESULTS: 
   Result =        no. of patients after treatment 
                                                         ________________________       X 100 
                   no. of patients before treatment 
Thus out of 40 patients before treatment, after treatment 75% of cases showed good 
result, 25% of the cases showed Moderate result. 
 
 
 
 
 
 
 
 
 
75% 
25% 
GRADING OF RESULTS 
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Peak Expiratory Flow Rate 
S. No BT 
 
AT 
1. 100 230 
2. 350 450 
3. 270 350 
4. 150 250 
5. 170 240 
6. 190 260 
7. 100 220 
8. 180 310 
9. 160 220 
10. 260 350 
11. 250 400 
12. 250 340 
13. 330 400 
14. 80 200 
15. 200 320 
16. 280 340 
17. 220 280 
18. 210 330 
19. 70 150 
20. 150 260 
21. 170 240 
22. 150 220 
23. 190 260 
24. 240 300 
25. 180 240 
26. 70 160 
27. 100 210 
28. 130 350 
29. 250 400 
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30. 230 340 
31. 200 350 
32. 260 350 
33. 170 260 
34. 190 280 
35. 130 310 
36. 250 340 
37. 280 360 
38. 350 420 
39. 180 280 
40. 120 200 
 
BT – Before Treatment ; AT – After Treatment 
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SL 
NO. 
OP 
NO 
AGE/ 
SEX 
HEMATOLOGICAL    REPORT URINE ANALYSIS RFT 
BEFORE TREATMENT AFTER TREATMENT ESR HB(gm) 
TC(Cu/mm) DC TC(Cu/m
m) 
DC BT AT   BT AT BT AT 
P L E P L E ½ 
Hr 
1 
Hr 
½ 
Hr 
1 
Hr 
BT AT A
l
b 
S
u
g 
Dep A
l
b 
S
u
g 
DEp Urea Cr
e 
Ure
a 
Cre 
1. 3205 52/F 8400 60 34 6 8600 61 38 1 3 7 2 5 13 13.2 - - OEC - - OEC 22 0.7 26 0.6 
2. 3293 55/F 9000 54 38 8 9200 55 39 6 12 20 8 12 12 12.4 - - OEC - - OEC 24 0.6 26 0.6 
3. 3303 49/F 9200 51 40 9 9100 60 38 2 6 14 3 7 12 12.4 - - OEC - - OEC 21 0.8 24 0.7 
4. 4406 46/F 8600 55 39 6 8900 61 36 3 5 20 4 15 12.4 12.8 - - OEC - - OEC 33 0.6 28 0.6 
5. 4407 51/F 9100 58 36 6 9200 59 37 4 3 29 2 5 14.2 13.6 - - OEC - - OEC 34 0.6 29 0.7 
6. 4352 13/F 8700 57 36 7 8600 60 38 2 6 15 7 14 13.5 13.4 - - OEC - - OEC 32 0.7 28 0.6 
7. 4496 45/F 9800 64 30 6 9200 61 36 3 5 8 4 6 10.6 11.6 - - OEC - - OEC 30 0.7 26 0.6 
8. 6031 32/F 9000 54 38 8 8900 56 40 4 10 21 5 15 11 13 - - OEC - - OEC 27 0.7 28 0.6 
9. 6143 24/M 9100 56 36 8 900 60 38 2 5 10 2 5 13 13.4 - - OEC - - OEC 24 0.6 26 0.5 
10. 5998 21/F 8700 60 34 6 8600 59 37 4 8 22 3 13 10.2 10.4 - - OEC - - OEC 19 0.6 23 0.6 
11. 6106 48/M 8300 59 36 5 8200 60 36 4 2 5 2 5 12 12.2 - - OEC - - OEC 23 0.7 27 0.6 
12. 6344 15/F 10100 59 32 9 9800 55 38 7 10 22 6 14 13 13 - - OEC - - OEC 22 0.6 25 0.6 
13. 6312 44/M 7900 55 37 8  8200 62 34 4 5 15 4 9 10.6 11 - - OEC - - OEC 21 0.7 24 0.7 
14. 7316 45/F 9500 58 36 6 9100 52 42 6 4 6 2 5 11 11 - - OEC - - OEC 30 0.6 28 0.7 
15. 7765 36/M 9000 53 40 7 9200 54 42 4 6 14 3 7 13 13.4 - - OEC - - OEC 32 0.6 28 0.7 
16. 8023 24/M 9100 52 40 8 8900 55 42 3 7 20 7 14 12 12.2 - - OEC - - OEC 20 0.8 24 0.6 
17. 8810 51/M 10200 61 33 6 10100 60 38 2 20 46 5 15 11 12.4 - - OEC - - OEC 24 0.7 22 0.6 
18. 8923 42/M 9300 62 30 8 9200 58 38 4 6 8 3 5 12.6 13 - - OEC - - OEC 21 0.7 26 0.6 
19. 9535 19/F 8100 58 33 9 8400 55 39 2 4 15 3 8 10.5 11.6 - - OEC - - OEC 30 0.6 29 0.7 
20. 9904 40/F 8800 58 36 6 8600 55 42 3 2 6 2 5 12 12.8 - - OEC - - OEC 31 0.6 27 07 
21. 1519 36/F 8000 59 33 8 8200 57 40 3 8 18 5 13 13.2 13.4 - - OEC - - OEC 32 0.6 28 0.6 
22. 1462 33/F 8200 60 32 8 8400 59 39 2 7 7 3 6 14 12.6 - - OEC - - OEC 27 0.7 28 0.6 
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BT – Befor Treatment, AT – After Treatment, TC – Total Count, DC – Differential Count, P – Polymorphs, L – Lymphocyte, 
E – Eosinophils, HB – Hemoglobin,  OEC – Occasional Epithelial Cells, RFT – Renal Function Tests, Cre – Creatinine. 
23. 2498 30/M 9300 57 35 8 9000 60 38 2 10 24 8 18 13 13 - - OEC - - OEC 24 0.7 26 0.6 
24. 6677 42/F 9700 58 36 6 9500 59 38 3 12 35 8 18 10 10 - - OEC - - OEC 26 0.6 27 0.7 
25. 6678 55/M 9100 62 31 7 9200 63 33 4 6 13 4 7 11 11.2 - - OEC - - OEC 33 0.6 28 0.6 
26. 6549 40/F 9300 60 31 9 9100 55 42 3 11 23 2 5 12 12.4 - - OEC - - OEC 30 0.7 28 0.7 
27. 6576 33/F 8600 55 39 6 8500 58 40 2 5 7 5 9 12 12.2  - OEC - - OEC 22 0.8 20 0.6 
28 6479 34/M 8100 57 36 7 8600 59 38 3 5 20 3 15 11 11 - - OEC - - OEC 21 0.6 24 0.6 
29. 6921 37/M 9600 58 34 8 9300 61 35 4 6 14 3 9 13 13 - - OEC - - OEC 28 0.5 26 0.7 
30. 8504 54/M 8300 61 30 9 8500 60 38 2 12 26 6 12 13 13.4 - - OEC - - OEC 18 0.6 20 0.6 
31. 8492 58/F 8500 56 37 7 8700 61 37 2 8 10 3 9 12.4 12.8 - - OEC - - OEC 25 0.8 22 0.7 
32. 8493 58/F 10,000 60 32 8 10100 61 36 3 12 25 7 14 9.2 11 - - OEC - - OEC 22 0.6 20 0.6 
33. 9836 39/F 8900 46 46 8 9000 52 46 2 32 65 8 20 12.7 12 - - OEC - - OEC 21 0.7 24 0.7 
34. 595 37/F 7800 55 39 6 8300 57 39 4 8 20 5 15 12.6 14 - - OEC - - OEC 26 0.6 24 0.6 
35. 603 48/M 8600 55 36 9 8400 57 38 5 7 15 3 6 12.4 13 - - OEC - - OEC 28 0.7 23 0.7 
36. 513 55/M 9200 51 42 7 9000 55 42 3 20 40 5 9 14.2 15 - - OEC - - OEC 21 0.6 25 0.6 
37. 1653 48/F 9000 61 33 6 9200 57 36 7 5 10 3 7 12 12.8 - - OEC - - OEC 26 0.8 23 0.7 
38. 1651 40/F 8400 54 40 6 8300 56 41 3 8 22 5 15 13.5 13.4 - - OEC - - OEC 25 0.6 22 0.6 
39. 3726 38/M 8200 62 31 7 8600 65 33 2 12 20 2 5 10 11.6 - - OEC - - OEC 28 0.7 26 0.7 
40. 8012 42/F 8700 56 38 6 8900 58 36 6 5 15 4 6 11 11.8 - - OEC - - OEC 22 0.8 20 0.5 
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SPECIFIC INVESTIGATION OF THE PATIENT 
 
BT – Before Treatment ; AT – After Treatment 
 
S. NO 
 
OP NO 
 
AGE/SEX 
 
OCCUPATION 
 
 
Abs.Eosin.Count 
 
X ray chest PA View 
 
BT 
 
AT 
 
BT 
 
AT 
1. 3205 52/F House wife 550 260 Normal Normal 
2. 3293 55/F House wife 400 180 Normal Normal 
3. 3303 49/F House wife 720 350 Normal Normal 
4. 4406 46/F House wife 500 310 Normal Normal 
5. 4407 51/M Office 900 420 Normal Normal 
6. 4352 13/F Student 240 180 Normal Normal 
7. 4496 45/F House wife 680 280 Normal Normal 
8. 6031 32/F House wife 640 320 Normal Normal 
9. 6143 24/M Office 300 170 Normal Normal 
10. 5998 21/M Office 320 270 Normal Normal 
11. 6106 48/F House wife 700 340 Normal Normal 
12. 6344 15/F Student 200 160 Normal Normal 
13. 6312 44/M Traffic police 640 270 Normal Normal 
14. 7316 45/F House wife 280 200 Normal Normal 
15. 7765 36/M Business 620 310 Normal Normal 
16. 8023 24/M Office 340 270 Normal Normal 
17. 8810 51/M Office 680 300 Normal Normal 
18. 8923 42/M Tailor 720 320 Normal Normal 
19. 9535 19/F Student 430 350 Normal Normal 
20. 9904 40/F House wife 850 380 Normal Normal 
21. 1519 36/F House wife 460 210 Normal Normal 
22. 1462 33/F House wife 320 220 Normal Normal 
23. 2498 30/M Office 300 260 Normal Normal 
24. 6677 42/F Office 670 280 Normal Normal 
25. 6678 55/M Office 820 360 Normal Normal 
26. 6549 40/F House wife 600 310 Normal Normal 
27. 6576 33/F House wife 350 230 Normal Normal 
28 6479 34/M Office 220 100 Normal Normal 
29. 6921 37/M Office 620 310 Normal Normal 
30. 8504 54/M Office 380 190 Normal Normal 
31. 8492 58/F House wife 460 200 Normal Normal 
32. 8493 58/F House wife 350 240 Normal Normal 
33. 9836 39/F House wife 300 210 Normal Normal 
34. 595 37/F House wife 250 160 Normal Normal 
35. 603 48/M Office 850 380 Normal Normal 
36. 513 55/M Business 720 340 Normal Normal 
37. 1653 48/F House wife 440 300 Normal Normal 
38. 1651 40/F House wife 380 220 Normal Normal 
39. 3726 38/M Office 560 240 Normal Normal 
40. 8012 42/F House wife 680 280 Normal Normal 
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DISCUSSION 
 Bronchial asthma is characterised by chronic airway inflammation and 
increased airway hyper-responsiveness leading to symptoms of wheeze, cough, chest 
tightness, and dyspnoea. It is characterised functionally by the presence of airflow 
obstruction which is variable over short periods of time, or is reversible with 
treatment. 
 Swasakasam is a clinical entity described by Yugimunivar in his Yugi Vaidhya 
Chinthamani 800. The classical symptoms are dyspnoea, cough, tightness of chest and 
wheezing. These clinical features can be well compared with Bronchial Asthma. 
 As per Siddha literature Sombu Theeneer was selected for Swasakasam from 
the Siddha Vaithyathirattu. 
AUTHENTICATION: 
 Based upon the organoleptic characters, microscopic and macroscopic 
examination of market sample Sombu (Pimpinella anisum) belongs to the family 
Apiaceae was done and authenticated by the Botanist, Department of Medicinal 
Botany, Govt. Siddha Medical College, Arumbakkam, Chennai-600106. 
PHYSIO CHEMICAL ANALYSIS: 
The Sombu Theeneer was evaluated for various physiochemical parameters and the 
mean value of volatile matter-0.049%, total solids – nil, Specific gravity – 0.95, and 
p
H 
value (10%) – 6.5 was analysed. 
TOXICITY STUDY: 
The experimental protocol was approved by The Institutional Animal Ethics 
Committee of Sathyabama University, Chennai, Tamil Nadu, India. IAEC Reference 
No: SU/ CLATR/IAEC/IV/024/2016 
Acute oral toxicity study followed as per OECD 423 guidelines and dose used was 
2.5ml/kg body weight and Sub-acute oral toxicity study done as per OECD 407 guide 
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lines, here dose utilized was 0.25ml for low and 0.5ml for high dose. These toxicity 
studies revealed no toxicity in Sombu Theeneer. The results of haematological 
analysis, biochemical analysis revealed no significant changes in the values when 
compared with those of respective controls. Then the histo-pathological examination 
of animals in control as well as the treated groups did not reveal any abnormalities.  
PHARMACOLOGICAL EVALUATION: 
The experimental protocol was approved by The Institutional Animal Ethics 
Committee of Sathyabama University, Chennai, Tamil Nadu, India. IAEC: IAEC: 
SU/CLATR/IEAC/VII/054/2016.The pharmacological activity of Sombu Theeneer 
was screened against milk induced eosinophilia in mice model. This proves that 
Sombu Theeneer has Bronchodilator activity. 
BIO CHEMICAL ANALYSIS: 
Biochemical assays are needed to evaluate disease models and to drive 
biomarker analysis in translational medicine and clinical research.  
Based on the analysis Sombu Theeneer exhibits the properties of alkaloids, 
Potassium and Chloride.  
IEC AND CTRI: 
IEC has approved my Sombu Theeneer with the allowed sample size of 40 
patients with combined gender IEC NO: GSMC-CH-ME-4/2015/006. 
The global mandate is to register all clinical trials prospectively, i.e. before the 
enrolment of the first patient I had successfully registered my trial drug by submitting 
the details and scientific data’s to CTRI. CTRI NO:  REF/2016/12/012911 
 
CLINICAL STUDY: 
Clinical studies were conducted followed by CTRI registration with the 
sample size of 40 patients. In my study, 40 patients with Swasakasam were selected in 
the Department of Maruthuvam, Government Siddha Medical College, attached to 
Arignar Anna Govt Hospital for Indian Medicine, Arumbakkam, Chennai -106.All 
necessary investigations were carried out to all patients and trial medicine was given. 
The results of before and after treatment of all the patients were analysed and 
discussed below. 
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AGE DISTRIBUTION: 
Out of 40 patients, high incidence of cases were noted in age group ranging from 31–
40 years 
SEX DISTRIBUTION: 
Out of 40 patients, 17 cases (42.5%) were male and 23 cases (57.5%) were female. 
Recent studies show that more women are Asthmatic than men. 
OCCUPATIONAL STATUS: 
Out of 40 patients, 3 patients (7.5%) were business man, 6 patients (15%) were 
housewife, 5 patient(12.5%)  was traffic policeman, 3 patient (7.5%) were student, 9 
patient (22.5%) was tailor, 14 patient (35%) were office people.. 
SOCIO-ECONOMIC STATUS: 
Regarding the socio-economic status, 23 patients (57.5%) comes under poor 
category,9 patients (22.5%) comes under middle category, and 8 patients (20%) 
comes under high class category. 
DIETARY HABITS: 
Out of 40 patients, 7 patients (17.5%) have Vegetarian diet and 33 patients (82.5%) 
have Mixed diet.    
PARUVAKAALAM: 
From selected 40 patients,16 patients (40%) comes under Kaarkaalam, 9 patients 
(22.5%) comes under Koothirkaalam,7 patients(17.5%) comes under Munpani,5 
patients (12.5%) comes under Pinpani, 2 patinets(5%) comes under Elavenil, 1patient 
(2.5%) comes under Mudhuvenil. 
Kaarkaalam, koothirkaalam and munpani seasons have a great impact on 
Swasakasam. 
THINAI:  
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Out of 40 patients, 33 patients (82.5%) comes under Neidhal,7 patients (17.5%) 
comes under Marudham. 
DURATION OF ILLNESS: 
Out of 40 patients, 6 patients(15%) belongs to less than one year duration, 25 
patients(62.5%) comes under 1-5 year duration, 5 patients(12.5%) comes under 6-
10year duration, and 4 patients (10%) have more than 10 years duration. 
MUKKUTRAM CLASSIFICATION: 
In Vatham: 
From the selected 40 patients 
i. Pranan was affected in 40 patients (100%), reflected as difficulty in breathing 
ii. Udhanan was affected in 40 patients (100%), reflected as cough 
iii. Abanan was affected in 5 patients (12.5%) reflected as constipation 
iv. Viyanan was affected in 35 patients (87.5%), reflected as body pain 
v. Samanan was affected in 14 patients (35%), reflected as loss of appetite 
vi. Koorman was affected in3 patients(7.5%), reflected as cough and sneezing 
vii. Devathathan was affected in 40 patients (100%) resulting in fatigue 
In Pitham: 
 Out of 40 patients 
i. Analagam was affected in 14 patients (35%), producing loss of appetite 
ii. Ranjagam was affected in 9 patients (22.5%), resulting in pallor of tongue. 
iii. Saathagam was affected in 40 patients (100%), producing fatigue in routine 
work 
In Kabham: 
 Out of 40 patients  
i. Avalambagam was affected in 40 patients (100%) reflected as difficulty in 
breathing. 
ii. Klethagam was affected in 14 patients (35%) results in loss of appetite. 
iii.  Santhigam was affected in 5 patients (12.5%) results in joint pain. 
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EZHU UDAL THATHUKKAL 
1. Saaram affected in all patients (100%) results in tiredness, general debility. 
2. Senneer affected in all cases (22.5%) causing pallor, dryness. 
3. Enbu affected in 26 patients (12.5%) causing back pain and joint pain. 
 
ENVAGAITHERVUGAL: 
1. Naa affected in all 9 patients(30%) results in palor of tongue 
2. Mozhi affected in 1 patients (2.5%) results difficult to speak. 
3. Vizhi affected in 9 patients(22.5%) pallor of lower eyelids. 
4. Malam affected in 5 patients (2.5%) results in constipation. 
5. Nadi  affected in 40patients (100%) . 
Naadi: 
Out of 40 patients, 31 patients had Kabhavatha naadi and 9 patients had Vathakabha 
naadi. 
             : 
 “                       ” 
-          
Neikuri: 
 Out of 40 patients, 9 patients (22.5%) had Vatha neer, 31 patients (77.5%) had 
Kabha neer. 
Signs and symptoms: 
Out of 40 patients, 40 patients (100%) had Dyspnoea, 30 patients (75%) had cough 
with expectoration, 40% patients (100%) had wheezing, 35 patients (87.5%) had 
tightness of chest, 6 patients (15%) had rhinitis, 6 patients (15%) had Sneezing, 4 
patients (10%) had headache. 
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Clinical prognosis: 
Out of 40 patients, 
Before treatment 40 patients had dyspnoea, wheezing, 35 patients had tightness of 
chest, 30 patients had cough with expectoration, treatment 6 patients had rhinitis and 
sinusitis and 4 patients had headache, after treatment 37 patients cured, only 3 patients 
had dyspnoea and wheezing and one had headache. Rest all had no symptom. 
Laboratory assessment: 
Before treatment in the blood parameters ESR, Polymorphs, Leucocytes, Eosinophil 
were elevated and after treatment all these parameters reduced to their normal limits. 
Before treatment Absolute eosinophil count was above 400 of patient and after 
treatment the absolute count reduced to normal range 350 and eosinophil reduced to 
normal 5. 
Peak expiratory flow rate:  
Before treatment 40 patients had abnormal peak flow rate, after treatment  (75%) got 
good results and 10 patients (25%) got moderate results. 
Suvai mukkuttra theory: 
Swasakasm is primarily due to deranged of vatham and iyya kuttram. The ingredient 
Sombu  have the property kaarpu suvai of neutralizing the deranged iyya kutram. 
Bio Statistics: 
 Since the p value P<0.01 is significant in all signs and symptoms. So there is 
significant reducing of signs & symptoms among the patients for the treatment of 
Swasakasam. Hence it is concluded that the treatment was effective and significant. 
Since the P value is highly significant (<0.001). So there is significant increasing of 
Peak Expiratory Flow Rate among the patients for the treatment of Swasakasam. 
Hence it is concluded that the treatment was effective and significant. 
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Grading of results: 
No. of patients after treatment  
Results =         ________________________        X 100                                 
                      No. of patients before treatment 
 
Thus out of 40 patients before treatment, after treatment 75% of cases showed good 
result, 25% of the cases showed Moderate result. 
SUMMARY 
SOMBU THEENEER FOR SWASAKAASAM  Page 95 
 
 
 
 
 
 
SUMMARY 
 
 
 
 
 
 
 
 
 
SUMMARY 
SOMBU THEENEER FOR SWASAKAASAM  Page 96 
SUMMARY 
                The clinical study on Swasakasam was carried out on Post graduate 
department of Maruthuvam, Government Siddha Medical College, Arignar Anna 
Hospital, Chennai-106 during the period of 2015 -2017.  
                 A total of 40 patients were treated in the Outpatient department. The 
clinical and pathological assessment was carried out on the basis of Siddha and 
Modern aspects. 
                 All patients were treated with SOMBU THEENEER (15ml bid with equal 
amount of warm water) for duration of 30 days. 
 The peak incidence of Swasakasam was found to be in 31-40 years of 
age group of both sexes. 
 The prevalence of the disease was high among Lower class populations 
57.5% followed by Middle class 22.5% and High class population 20%. 
 Out of 40 patients, 9 patient (22.5%) was tailor, 14 patient (35%) were 
office people, 5patient (12.5%) was traffic policeman, 3 patients (7.5%) 
were business man, 6 patients (15%) were housewife, 3 patient (7.5%) 
were student. 
 Regarding personal habits 11 patients were smokers, 4 patients were 
alcoholic, 3 patients were both smoking and alcoholic, 1 patient was a 
snuff user. Remaining 21 patients were tee tootlers. 
 Among the dietary patterns, 82.5% consume mixed diet and 17.5% are 
purely vegetarian. 
 Out of 40 patients, 37.5% comes under Vatha kaalam, 62.5% comes 
under Azhal kaalam. 
 From selected 40 patients,16 patients(40%) comes under Kaarkaalam, 9 
patients(22.5%) comes under Koothirkaalam,7 patients(17.5%) comes 
under Munpani,5 patients (12.5%) comes under Pinpani, 2 patients(5%) 
comes under Elavenil, 1patient (2.5%) comes under Mudhuvenil. 
 Out of 40 patients, 33 patients (82.5%) comes under Neidhal,7 patients 
(17.5%) comes under Marudham. 
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 From the selected 40 patients, Pranan was affected in 40 patients (100%), 
Abanan was affected in 5 patients (12.5%), Viyanan was affected in 35 
patients (87.5%),Samanan was affected in 14 patients (35%),Koorman 
was affected in3 patients(7.5%), Kirugaran was affected in 30 patients 
(75%), Devathan was affected in 40 patients (100%). 
 Out of 40 patients, Analagam was affected in1 4 patients (35%), 
Ranjagam was affected in 9 patients (22.5%), Saathagam was affected in 
40 patients (100%), Aalosagam was affected in 3 patients (7.5%). 
 Out of 40 patients, Avalambagam was affected in 40 patients (100%), 
Klethagam was affected in 14 patients (35%), Santhigam was affected in 
5 patients (12.5%). 
 Out of 40 cases, Saaram was affected in 40 patients (100%), Seneer was 
affected in 9 patients(22.5%), Enbu was affected in 5 patients(12.5%). 
 Regarding Envagaithervu, Naa was affected in 9 patients(22.5%), Mozhi 
was affected in 1 patients(2.5%), Vizhi was affected in 9 
patients(22.5%), Malam was affected in 5 patients (12.5%), Naadi was 
affected in 40 patients(100%). 
 Out of 40 patients, 31 patients had Kabhavatha naadi and 9 patients had 
Vathakabh anaadi. 
 Out of 40 patients, 9 patients (22.5%) had Vatha neer, 31 patients 
(77.5%) had Kabhaneer. 
 Regarding peak expiratory flow rate (75%) got good results and 10 
patients (25%) got moderate results. 
 The ingredient Sombu has the property kaarpu suvai of neutralizing the 
deranged iyya kutram. 
 The toxicity studies revealed no toxicity in SombuTheeneer. 
 The pharmacological activity of SombuTheeneer shows Bronchodilator 
activity. 
 The Biostatsistical report of the clinical trial significant p value P<0.01 
and concluded that the treatment was effective and significant. 
 Thus out of 40 patients before treatment, after treatment 75% of cases 
showed good result, 25% of the cases showed Moderate result. 
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CONCLUSION 
 
Swasakasam is primarily due to the derangement of Iyyam and Vatha kutram. 
 The ingredients of the trial medicine have the properties of neutralizing 
the deranged kutrams. 
 From the preclinical toxicity studies, the trial medicine revealed no 
toxicity and proved to be safe. 
 From  the  preclinical  pharmacological  studies,  it  is  evident  that  
SOMBU THEENEER  have Bronchodilator activity. 
 No contraindication was reported during the course of the treatment. 
 The SOMBU THEENEER   gave maximum relief from the symptoms of 
Swasa kasam. 
 The reduces SOMBU THEENEER the frequency of wheeze attacks. 
 The SOMBU THEENEER  is economical and easily palatable. 
Therefore I conclude that, can give a SOMBU THEENEER will be the best 
remedie for asthma sufferers both curative and preventive. 
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PHARMACOLOGICAL STUDY 
Pharmacological Evaluation of Bronchodilatory activity of Sombu 
Theeneer against milk induced eosinophilia in mice. 
Name : Dr.R.Kalpana 
IAEC: SU/CLATR/IEAC/VII/054/2016 
Experimental Animals 
Healthy Swiss albino male mice weighing between 20-25 g were used for the 
study.  The animals were housed in poly propylene cages and were kept in well 
ventilated with 100% fresh air by air handling unit (AHU). A 12 light / dark cycle 
were maintained .Room temperature was maintained between 22 + 2
0 
Cand relative 
humidity 50–65%. They were provided with food (Sai feeds, Bangalore, India) and 
water ad libitum. All the animals were acclimatized to the laboratory for 7 days prior 
to the start of the study. The experimental protocol was approved by The Institutional 
Animal Ethics Committee of Sathyabama University, Chennai, Tamil Nadu, India. 
IAEC SU/CLATR/IEAC/VII/054/2016 
Experimental Methodology 
Animals were randomly divided in four group of 6 male mice each (one 
normal control, second milk intoxicated, three and four treatment groups).Animal 
belongs to group I received normal saline 0.1ml. Group II mice received boiled and 
cooled milk (4 mL/kg, s.c.) from day 1 to 5. Animal belongs to group III received 
milk (4 mL/kg, s.c.) and treated with 0.05 ml of Sombu Theeneer (p.o) 1 hr before 
milk injection for five days. Animal belongs to group IV received milk (4 mL/kg, s.c.) 
and treated with 0.1 ml of Sombu Theeneer (p.o) 1 hr before milk injection for five 
days. 
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Induction of Leukocytosis 
Swiss albino male mice were used for this study in which boiled and cooled milk (4 
mL/kg, s.c.) was injected to the mice results in abnormal increase in Total WBC, 
Procalcitonin, eosinophil count. 
Blood collection 
At the end of the study after overnight fast all mice were anesthetized by intra 
muscular injection with pentobarbital sodium. Blood will be collected by ocular 
puncture for biochemical estimations of Total WBC, Procalcitonin, eosinophile count. 
Histopathology 
At the ends of the study all the mice will be sacrificed and lung was harvested and 
stored in the fixative solution (10% formalin) and cut into 10 μm thickness. Staining 
was done by using hematoxylin and eosin 
Reference: 
1. Dnyaneshwar J Taur. Effect of Abrus precatorius leaves on milk induced 
leukocytosis and eosinophilia in the management of asthma.Asian Pacific 
Journal of Tropical Biomedicine (2012);S40-S42 
2. Parasuraman S, Raveendran R, Kesavan R. Blood sample collection in small 
laboratory animals. J Pharmacol Pharmacother. 2010;1:87–93. 
3. Verley H. Practical Clinical Biochemistry. New Delhi: CBS Publishers; 2003. 
Effect of Sombu Theeneer on hematology profile of mice challenged against milk 
induced eosinophilia 
GROUP I 
 WBC 
count 
(×10
3
 µl) 
Eosinophil’s 
(%) 
Neutrophils 
10
3
/mm
3
 
Lymph        
(%) 
Mon            
(%) 
PCT      
(%) 
Mean 3.117 0.4033 1.617 69.18 2.75 0.3957 
Std. Deviation 1.412 0.1097 0.4401 5.363 0.6317 0.201 
Std. Error 0.5764 0.04477 0.1797 2.19 0.2579 0.08206 
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GROUP II 
 WBC 
count 
(×10
3
 µl) 
Eosinophil’s 
(%) 
Neutrophils 
10
3
/mm
3
 
Lymph        
(%) 
Mon            
(%) 
PCT      
(%) 
Mean 10.28 2.513 3.467 90.65 6.267 2.655 
Std. Deviation 2.184 0.5483 0.6743 3.266 0.8262 0.768 
Std. Error 0.8916 0.2238 0.2753 1.333 0.3373 0.3135 
GROUP III 
 WBC 
count 
(×10
3
 µl) 
Eosinophil’s 
(%) 
Neutrophils 
10
3
/mm
3
 
Lymph        
(%) 
Mon            
(%) 
PCT      
(%) 
Mean 6.433 1.457 2.833 80.38 5.2 1.432 
Std. Deviation 1.919 0.218 0.3777 9.439 0.8786 0.4806 
Std. Error 0.7834 0.08898 0.1542 3.854 0.3587 0.1962 
GROUP IV 
 WBC 
count 
(×10
3
 µl) 
Eosinophil’s 
(%) 
Neutrophils 
10
3
/mm
3
 
Lymph        
(%) 
Mon            
(%) 
PCT      
(%) 
Mean 4.183 0.7 2.4 75.05 3.883 0.8655 
Std. Deviation 0.9517 0.139 0.4817 4.195 0.5845 0.1425 
Std. Error 0.3885 0.05675 0.1966 1.712 0.2386 0.0582 
Values are mean ± S.D / S.E (n = 6 per group) 
Effect of Sombu Theeneer on Lung weight of mice challenged against milk  
GROUP I 
Lung Weight in gms 
Mean 0.18 
Std. Deviation 0.02098 
Std. Error 0.008563 
GROUP II Lung Weight in gms 
Mean 0.425 
Std. Deviation 0.04037 
Std. Error 0.01648 
GROUP III Lung Weight in gms 
Mean 0.33 
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Std. Deviation 0.03347 
Std. Error 0.01366 
GROUP IV Lung Weight in gms 
Mean 0.2283 
Std. Deviation 0.03312 
Std. Error 0.01352 
 
Histopathology of Mice Lung (H&E) Staining 
Low Power Magnification 10 X 
Control Group           Milk alone Treated group Milk+ Low dose of ST Milk+ High dose of ST 
       
  
 High Power Magnification 40 X 
        
 
Pathology Report 
 Lung parenchyma appears normal with regular arrangement of alveoli and 
alveolar sac with no signs of lymphocyte infiltration and pulmonary fibrosis 
 Mild airway and bronchial secretion with collateral bronchial blood vessels 
and connective tissue .Evidence of pulmonary edema and vascular congestion 
was observed in group II sample.  
 Massive recruitment of eosinophil’s around the airway, blood vessels and 
bronchoconstriction was observed in sample belongs to group II. 
 Mild eosinophilic aggregation around air way with dilated bronchial opening 
was observed in group III.  
 Regular appearance of pulmonary artery, alveolar duct was normal with wide 
bronchial orifice was observed in group IV. 
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SOMBU THEENEER FOR SWASA KAASAM  Page 136 
PHYSICO CHEMICAL ANALYSIS
 
BIOCHEMICAL ANALYSIS 
 
SOMBU THEENEER FOR SWASA KAASAM  Page 137 
BIO-CHEMICAL ANALYSIS OF TRIAL MEDICINE 
 
Preparation of Sodium Carbonate extract: 
 
2 gm of the sample drug is mixed 5 gm of Sodium carbonate and taken in a 
100 ml beaker and 20 ml of distilled water is added. The solution is boiled for 10 
minutes, cooled and then filtered. The filtrate is called sodium carbonate extract. 
 
S. 
No 
EXPERIMENT OBSERVATION INFERENCE 
I TEST FOR ACID RADICALS 
1a Test for Sulphate 
2 ml of the above prepared extract is 
taken in a test tube. To this add2ml of 
4% Ammonium oxalate solution. 
Absence of 
White Precipitate 
Absent 
b 2ml of extract is added with 2mlof 
dilute hydrochloric acid until the 
effervescence ceases off. Then2ml 
barium chloride solution is added. 
Absence of 
White Precipitate 
Absent 
2 Test for Chloride: 
2ml of extract is added with dilute nitric 
acid till the effervescence ceases. Then 
2ml of silver nitrate solution is added. 
Presence of 
white precipitate 
 
Present 
3 Test for Phosphate 
2ml of the extract is treated 
with 2 ml of Ammonium 
molybdate solution and 2ml of 
concentrated nitric acid. 
 
Yellow precipitate 
obtained 
 
 
 
Absent 
4 Test for Carbonate: 
2ml of the extract is treated 
with 2ml of magnesium 
sulphate solution. 
 
Absence of white 
precipitate 
Absent 
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5 Test for Sulphide: 
1 gm of the substance is treated 
with 2ml of concentrated 
Hydrochloric acid 
Absence of Rotten 
egg smelling 
Absent 
6 Test for Nitrate: 
1gm of the substance is heated 
with copper turnings and 
concentrated sulphuric acid 
and viewed the test tube 
vertically down. 
Absence of reddish 
brown gas. 
Absent 
 
7a Test for Fluoride and oxalate 
2ml of the extract is added with 
2ml of dilute acetic acid and 
2ml of calcium chloride 
solution and heated. 
Absence of 
White precipitate 
Absent 
b 5 drops of clear solution is 
added with 2ml of dilute 
sulphuric acid and slightly 
warmed to this, 1 ml of dilute 
potassium permanganate 
solution is added. 
Absence of KMNO4 
solution 
Discolourisation 
obtained 
Absent 
8 Test for Nitrite 
3 drops of the extract is placed 
on a filter paper. On that, 2 
drops a Acetic Acid and 2 
drops of Benzidine solution is 
placed. 
Absence of 
yellowish red colour 
Absent 
 
 
 
 
BIOCHEMICAL ANALYSIS 
 
SOMBU THEENEER FOR SWASA KAASAM  Page 139 
9 Test for Borate 
2 pinches of the substance is 
made into paste by using 
Sulphuric acid and Alcohol 
(95%) and introduced into the 
blue flame. 
Absence of Green 
tinged flame 
Absent 
II TEST FOR BASIC RADICALS 
10 Test for lead 
2 ml of the extract is added 
with 2 ml of Potassium iodide 
solution. 
Absence of Yellow 
precipitate 
Absent 
11a Test for Copper 
One pinch of substance is 
made into paste with 
concentrated Hydrochloric 
acid 
in a watch glass and 
introduced 
into the non luminous part of 
the flame. 
Absence of Bluish 
green coloured 
flame. 
Absent 
b 2ml of the extract is added 
with 
excess of Ammonia solution 
Absence of deep 
blue 
Absent 
12 Test for Aluminium 
To the 2 ml of extract. Sodium 
Hydroxide solution is added in 
drops to excess. 
Absence of White 
Precipitate. 
Absent 
13a Test for Iron 
To the 2 ml of extract, 2 ml of 
Ammonium Thiocyanate 
Solution is added. 
No Blood red colour Absent 
b To the 2 ml of extract, 2 ml of Absence of Blood red colour Absent 
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Ammonium Thiocyanate 
solution and 2 ml of 
concentrated HNO3 is added. 
obtained 
14 Test for Zinc 
To the 2 ml of extract Sodium 
Hydroxide solution is added in 
drops to excess. 
Absence of White 
precipitate. 
Absent 
15 Test for Calcium 
2 ml of the extract is added 
with 2 ml of 4% Ammonium 
Oxalate solution. 
Absence of White precipitate 
Obtained 
Absent 
16 Test for Magnesium 
2ml of extract, Sodium 
Hydroxide solution is added in 
drops to excess. 
Absence of White 
precipitate. 
Absent 
17 Test for Ammonium 
2 ml of extract few ml of 
Nessler’s Reagent and excess 
of Sodium Hydroxide solution 
are added. 
Absence of 
Reddish brown 
precipitate 
Absent 
18 Test for Potassium 
A pinch of substance is treated 
with 2 ml of Sodium Nitrite 
solution and then treated with 
2 
ml of Cobalt Nitrate in 30% 
glacial Acetic acid. 
Presence of Yellow precipitate 
 
Present 
19 Test for Sodium 
2 pinches of the substance is 
made into paste by using 
Hydrochloric acid and 
introduced into the blue flame 
 
Absence of Yellow 
colour flame 
Absent 
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20 Test for Mercury 
2 ml of the extract is treated 
with 2 ml of Sodium 
Hydroxide solution. 
Absence of yellow 
precipitate 
Absent 
21 Test for Arsenic 
2 ml of extract is treated with 
2 
ml of silver Nitrate solution 
Absence of 
Yellow precipitate 
Absent 
22 Test for Starch 
2ml of extract is treated with 
weak iodine solution 
Absence of 
Blue colour 
Absent 
23 Test of reducing Sugar 
5ml of Benedicts qualitative 
solution is taken in a test tube 
and allowed to boil for 2 
minutes and added 10 drops of 
the extract and again boiled 
for 
2 minutes. The colour changes 
are noted. 
No  Green colour obtained Absent 
24 Test of the alkaloids 
2ml of the extract is treated 
with 2ml of potassium iodide 
solution. 
Presence of 
Red colour 
Present 
25 Test of the proteins 
2ml of the extract is treated 
with 2ml of 5% NaOH ,mix 
well and add 2 drops of copper 
sulphate solution. 
Absence of 
Violet colour 
Absent 
RESULTS: 
The given sample (Sombu Theeneer) contains Chloride, Potassium and 
Alkaloids. 
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BIOSTATISTICAL ANALYSIS 
CLINICAL PROGNOSIS 
Treatment for Swasakasam: 
The most popular non parametric statistical tool, namely, McNemar Test 
analysis has been employed to analyses the effectiveness with the help of a 
hypothesis. 
S. 
No 
Signs&Symptoms Before Treatment After Treatment 
n% n% 
1. Dyspnoea 40(100) 3(7.5)** 
2. Cough without 
expectoration 
30(75) 0(0)** 
3. Wheezing 40(100) 3(7.5)** 
4. Tightness of chest 35(87.5) 0(0)** 
5. Rhinitis 6(15) 0(0)* 
6. Sneezing 6(15) 0(0)* 
7. Headache 4(10) 1(2.5)*   
 
McNemat test, C.I: 95%,  *P<0.05; **P<0.01 
Software: spss17 version 
Number of cases: 40 
Inference:  
Since the p value is significant in all signs and symptoms.So there is 
significant reducing of signs & symptoms among the patients for the treatment of 
Swasakasam.Hence it is concluded that the treatment was effectiveand significant. 
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PEAK EXPIRATORY FLOW RATE BEFORE AND AFTER TREATMENT 
Effect of medicineon Peak Expiratory Flow Ratein human subjects 
S.No. BT 
 
AT 
1 100 230 
2 350 450 
3 270 350 
4 150 250 
5 170 240 
6 190 260 
7 100 220 
8 180 310 
9 160 220 
10 260 350 
11 250 400 
12 250 340 
13 330 400 
14 80 200 
15 200 320 
16 280 340 
17 220 280 
18 210 330 
19 70 150 
20 150 260 
21 170 240 
22 150 220 
23 190 260 
24 240 300 
25 180 240 
26 70 160 
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27 100 210 
28 130 350 
29 250 400 
30 230 340 
31 200 350 
32 260 350 
33 170 260 
34 190 280 
35 130 310 
36 250 340 
37 280 360 
38 350 420 
39 180 280 
40 120 200 
 
Software: spss17 version 
Variables:Peak Expiratory Flow Rate – before treatment, after treatment 
Number of cases: 40 
Test: Paired t test 
Confidence Interval: 95% 
Correlation coefficient (r): 0.897 
Before and after treatment mean difference± SD: 99.48 ± 35.61. 
P Value (2 tailed): p<0.001. 
Inference:  
Since the P value is highly significant (<0.001). So there is significant increasing of 
Peak Expiratory Flow Rate among the patients for the treatment of Swasakasam. 
Hence it is concluded that the treatment was effective and significant 
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CONSENT FORM 
 
I certify that I have disclosed all the details about the study in the 
terms readily understood by the patient. 
 
DATE :       SIGNATURE 
NAME: 
 
CONSENT BY THE PATIENT 
 
I have been informed to my satisfaction by the attending physician 
about the purpose of clinical trial and the nature of the drug treatment and 
follow up including the lab investigations to be performed to monitor and 
safeguard my body functions. I am aware of my right to opt out of the trial at 
any time during the course of the trial without having to give reasons for 
doing so. I am exercising my free power of choice, and hereby give my 
consent to be included as a subject in the clinical trial of SOMBU 
THEENEER for the treatment of SWASAKASAM. 
 
 
DATE :                                                                                   SIGNATURE 
NAME: 
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அரசு சித்த மருத்துவக் கல்லூரி, சசன்னை-106 
அறிஞர் அண்ணா மருத்துவமனை, சசன்னை 
சுவாசகாச ந ாய்க்காை சித்த மருந்தின் (நசாம்பு தீ ீர்)பரிகரிப்பு திறனைக் 
கண்டறியும் மருத்துவ ஆய்வுற்காை தகவல் படிவம். 
ஒப்புதல் படிவம் 
ஆய்வாளரால் சான்றளிக்கப்பட்டது 
 ான் இந்த ஆய்வு குறித்த அனைத்து விபரங்கனளயும் ந ாயாளிக்கு 
புரியும்வனகயில் எடுத்துனரத்நதன் எை உறுதியளிக்கிநறன். 
நததி:         னகசயாப்பம்: 
இடம்:         சபயர்: 
ந ாயாளியின் ஒப்புதல் 
என்ைிடம் இந்த மருத்துவ ஆய்வின் காரணத்னதயும், மருந்தின் தன்னம 
மற்றும் மருத்துவ வழிமுனற பற்றியும், சதாடர்ந்து எைது உடல் இயக்கத்னத 
கண்காணிக்கவும்,அதனை பாதுகாக்கவும் பயன்படும் மருத்துவ ஆய்வுக்கூட 
பரிநசாதனைகள் பற்றி திருப்தி அளிக்கும் வனகயில் மருத்துரால் விளக்கிக் 
கூறப்பட்ட்து. 
 ான் இந்த மருத்துவ ஆய்வின் நபாது, காரணம் எதுவும் கூறாமல், 
எப்சபாழுது நவண்டுமாைாலும் இந்த ஆய்விலிருந்து என்னை விடுவித்து 
சகாள்ளும் உரினமனய சதரிந்திருக்கின்நறன். ான் என்னுனடய சுதந்திரமாக 
நதர்வு சசய்யும் உரினமனயக் சகாண்டுசுவாசகாச ந ாய்க்காைநசாம்பு தீ ீர் 
மருந்தின் பரிகரிப்புத் திறனைக் கண்டறியும் மருத்துவ ஆய்விற்கு என்னை 
உட்படுத்த ஒப்புதல் அளிக்கிநறன். 
நததி:        னகசயாப்பம்: 
இடம்:        சபயர்: 
நததி:        சாட்சிக்காரர் 
னகசயாப்பம்: 
இடம்:        சபயர்: 
உறவுமுனற: 
துனறத்தனலவர் னகசயாப்பம்:    ஆராய்ச்சியாளர் 
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O.P CASE SHEET PROFORMA 
 
POST GRADUATE DEPARTMENT, MARUTHUVAM (BRANCH-1) 
GOVERNMENT SIDDHA MEDICAL COLLEGE 
ARIGNAR ANNA GOVERNMENT HOSPITAL OF INDIAN MEDICINE 
CHENNAI – 600 106 
CLINICAL STUDY ON “SOMBU THEENEER” IN THE TREATMENT OF 
“SWASAKASAM’’ (BRONCHIAL ASTHMA) 
 
OP NO:     OCCUPATION: 
NAME:     INCOME: 
AGE:      NATIONALITY: 
SEX:      RELIGION: 
ADDRESS:     DIAGNOSIS: 
CONTACT NO:    MEDICAL OFFICER: 
COMPLAINTS & DURATION: 
HISTORY OF PRESENT ILLNESS: 
 
HISTORY OF PAST ILLNESS: 
 
PERSONAL HISTORY AND HABITS: 
 
DIETARY HABIT: FAMILY HISTORY: 
 
GENERAL EXAMINATION:
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Consciousness: 
Nourishment: 
Decubitus: Height (cms): 
Weight (kg): 
Temperature (°F): 
Pulse rate (/min): 
Heart rate (/min): 
Respiratory rate (min): 
Blood pressure (mm/Hg): 
Pallor: 
Jaundice: 
Cyanosis: 
Lymphadenopathy: 
Pedal edema: 
Clubbing: 
Jugular vein pulsation: 
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SIDDHA SYSTEM OF EXAMINATIONS: 
 
1. THEGI:  [BODY CONSTITUTION] 
 
1. Vatha udal 
2. Pitha udal 
3. Kaba udal 
4. Thontha udal 
 
2. NILAM: [LAND WHERE PATIENT LIVED MOST] 
 
1. Kurinji        (Hilly terrain) 
2. Mullai         (Forest range) 
3. Marutham   (Plains) 
4. Neithal        (Coastal belt) 
5. Paalai          (Arid regions) 
 
3. KAALAM: 
 
1. Kaar kaalam 
2. Koothir kaalam 
3. Munpani kaalam 
4. Pinpani kaalam 
5. Ilavenil kaalam 
6. Muthuvenil kaalam 
 
4. GUNAM: 
1. Sathuvam 
2. Raasatham 
3. Thaamatham 
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5. IMPORIGAL (SENSORY ORGANS): 
 
1. Mei (Sensation) 
2. Vaai (Taste) 
3. Kann (Vision) 
4. Mukku (Smell) 
5. Sevi (Hearing) 
 
6. KANMENDHIRIYAM (MOTOR ORGANS): 
 
1.   Kai 
4. Kal 
5. Vaai 
6. Eruvai 
7. Karuvaai 
 
7. KOSANGAL: 
 
1. Annamaya kosam 
2. Pranamaya kosam 
3. Manomaya kosam 
4. Vignana maya kosam 
5. Anandamaya kosam 
 
8. UYIR THAATHUKKAL: [THREE HUMORS] (VALI,  AZHAL, IYAM) A) 
VALI 
1. Pranan 
2. Abanan 
3. Samanan 
4. Uthanan 
5. Viyanan 
6. Naagan 
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7. Koorman 
8. Kirukaran 
9. Devathathan 
10. Dhananjayan 
B) AZHAL 
 
1. Analakam 
2. Ranjakam 
3. Sathakam 
4. Prasakam 
5. Alosakam 
 
C) IYAM 
 
1. Avalambagam 
2. Kilethagam 
3. Pothagam 
4. Tharpagam 
5. Santhigam 
 
9. EZHU UDAL THATHUKKAL: (SEVEN SOMATIC COMPONENTS) 
 
1. Saram 
2. Senneer 
3. Oon 
4. Koluppu 
5. Enbu 
6. Moolai 
7. Sukkilam/ suronitham 
 
10. ENVAGAI THERVU: 
 
I. NAADI: [Pulse Perception] 
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II. SPARISAM: [Palpation] 
III. NAA: [Tongue] 
IV. NIRAM: [Complexion] 
 
1. Vadham 
2. Pitham 
3. Kabam 
 
V. MOZHI: [Voice] 
 
1. High Pitched 
2. Low Pitched 
3. Medium Pitched 
 
VI. VIZHI: [Eyes] 
 
VII. MALAM: [Bowel Habits / Stools] Niram 
Irugal 
Ilagal 
 
VIII. MOOTHIRAM [Urine Examination] 
 
NEERKURI: 
Niram Manam Edai Nurai Enjal 
 
NEIKKURI 
 
MODERN ASPECTS 
 
EXAMINATION OF RESPIRATORY SYSTEM: Inspection: 
1. Shape/ type of the chest: 
2. Deformities of chest: 
3. Respiratory movements: 
4. Type of breathing: 
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5. Odema of chest wall: 
6. Visible pulsations: 
7. Distended veins over the chest wall: 
8. Wasting: 
 
Palpation: 
 
1. Position of the trachea: 
2. Apical impulse: 
3. Local swelling: 
4. Local tenderness: 
5. Enlarged lymphnodes: 
6. Vocal fremitus: 
 
Percussion: 
 
1. Over the clavicle: 
2. Supra clavicular: 
3. Infra clavicular: 
4. Axillary: 
5. Infra clavicular: 
6. Supra clavicular: 
7. Inter scapular: 
8. Infra clavicular: 
 
Auscultation: 
1. Adventitious sounds: Rales: 
      Rhonchi: 
2. Pleural friction: 
3. Vocal Resonance: 
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Other systems: 
 
1. Cardio vascular system: 
2. Gastro Intestinal system: 
3. Central Nervous system: 
4. Genito Urinary system 
 
SIGNS AND SYMPTOMS: 
 
S. No Assessment Before 
Treatment 
After treatment (week) 
I II III IV 
1. Dyspnoea      
2. Cough      
3. Chest tightness      
4. Wheezing      
5. Rhinitis      
6. Sneezing      
7. Headache      
8. Fever      
9. Cyanosis      
10. PEFR      
 
 
LABORATORY INVESTIGATIONS: 
 
1. Blood: TC: DC: ESR: Hb: Sugar: Cholesterol: Urea: Creatinine: 
Urine: Albumin: Sugar: Deposits 
 
 
2. PEAK EXPIRATORY FLOW RATE 
 
 
3. ABSOLUTE EOSINOPHIL COUNT 
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4. X RAY CHEST PA VIEW CASE SUMMARY 
 
 
 
FINAL DIAGNOSIS 
 
MEDICINE: 
 
SOMBU THEENEER- 15ML BD with warm water 
 
MEDICAL ADVICE 
BIBLIOGRAPHY 
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